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The  greatest  burden  of  disease  in  the  WHO  European  Region  is  attributable  to  noncommunicable  diseases.  As  one  of  
the  top  modifiable  behavioural  risk  factors,  tobacco  use  is  the  most  preventable  cause  of  death  and  diseases  that  can  
be  successfully  tackled  by  comprehensive  and  evidence-­based  tobacco  control  policies.  In  the  Region,  16%  of  all  
deaths  are  attributable  to  tobacco,  the  highest  rate  globally.  This  report,  10  years  after  the  adoption  of  the  WHO  
Framework  Convention  on  Tobacco  Control,  looks  back  and  takes  stock  of  the  situation  in  the  Region  in  order  to  
effectively  target  action  towards  a  decrease  in  tobacco  use  and  to  further  stimulate  the  discussion  on  the  vision  for  
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It  is  hard  to  imagine  but  not  long  ago,  the  use  of  tobacco  was  considered  safe,  smoking  was  permitted  on  
airplanes  and  doctors  and  nurses  were  even  promoting  tobacco  products.  If  we  showed  people  living  at  that  
time  the  future  of  tobacco  as  it  is  now,  and  how  far  we  have  succeeded  in  tobacco  control,  it  may  have  been  
hard  for  them  t????????????????????????????????????????? ???????????????????????????????????????????????????
goes  beyond  our  current  expectations?  Why  not  consider  a  world  where  all  public  places  are  smoke  free,  a  
world  where  all  tobacco  products  have  large  graphic  warnings  or  even  standardized  packaging,  a  world  
where  there  is  absolutely  no  advertising  of  tobacco  products?    
  
We  have  a  powerful  tool,  the  WHO  Framework  Convention  on  Tobacco  Control  (WHO  FCTC),  and  we  know  it  
works,  but  we  have  to  use  it  to  its  full  potential.  Ten  years  after  the  treaty  was  adopted,  we  see  the  number  
of  people  being  protected  by  tobacco  control  measures  growing  at  an  increased  pace.  But  to  achieve  the  
global  voluntary  noncommunicable  target  for  a  30%  relative  reduction  of  tobacco  use  by  2025,  do  we  need  to  
accelerate  our  pace?  This  report  shows  that  great  progress  has  been  made,  but  we  have  a  long  way  to  go  to  
full  implementation  of  the  WHO  FCTC.  Only  a  few  countries  in  the  Region  have  taken  a  comprehensive  
approach  to  implementing  the  WHO  FCTC.  Preliminary  projections  into  2025  reveal  that  stronger  action  is  
needed  to  meet  the  global  target.    
  
We  need  to  comprehend  the  magnitude  of  the  number  of  people  that  still  die  from  tobacco,  but  also  see  their  
faces  behind  this  number.  We  need  to  feel  the  urgency  of  the  lives  affected  by  tobacco  and  particularly  in  
these  times  of  limited  resources,  the  urgency  behind  the  economic  burden  of  tobacco  on  governments  and  on  
those  addicted.  We  need  to  scale  up  our  efforts.    
  
Why  not  consider  a  tobacco-­‐free  regi????????????????????????????????????? ?????????????????????????
countries  are  already  paving  the  way,  regionally  and  globally,  to  consider  this  vision  in  their  tobacco  control  
strategies.  For  these  and  for  all  others,  full  implementation  of  the  WHO  FCTC  is  the  first  step  in  the  direction  
to  a  tobacco-­‐free  region.    
  
We  need  to  expect  aggressive  resistance  from  the  tobacco  industry  every  step  of  the  way.  We  need  to  
approach  tobacco  control  in  a  well-­‐orchestrated  manner.  Coordination  among  different  sectors  in  a  country  
is  essential  and  in  our  globalized  world,  coordination  between  countries  is  paramount.  This  is  an  integral  
principle  behind  the  regional  health  policy  framework  Health2020,  and  the  WHO  FCTC  calls  for  such  an  
approach.  The  WHO  FCTC  is  based  on  evidence,  and  its  impact  is  an  inspiration  that  allows  us  to  dream  big  to  
accomplish  what  is  necessary.  Tobacco  control  is  Health2020  in  action.  
  
Zsuzsanna  Jakab  
WHO  Regional  Director  for  Europe  
  





Tobacco  kills  nearly  6  million  people  each  
year  worldwide,  more  than  HIV/AIDS,  
tuberculosis  and  malaria  combined.  
  
Unless  strong  action  is  taken,  this  number  
could  rise  to  more  than  8  million  by  2030  (1).  
  
Tobacco  use  or  exposure  to  tobacco  smoke  
negatively  impacts  health  across  the  life  course.  
  
During  fetal  development,  tobacco  can  increase  
rates  of  stillbirth  and  selected  congenital  
malformations.  In  infancy,  it  can  cause  sudden  
infant  death  syndrome.  In  childhood  and  
adolescence,  tobacco  can  cause  disability  from  
respiratory  diseases.  In  relatively  young  middle-­‐
aged  adults,  it  can  cause  increased  rates  of  
cardiovascular  disease  and,  later  in  life,  higher  
rates  of  cancer  (especially  lung  cancer),  as  well  as  
death  associated  with  diseases  of  the  respiratory  
system  (2).  
  
The  fight  against  tobacco  is  a  key  action  to  
help  decrease  noncommunicable  diseases  
(NCDs).  
  
Tobacco  control  measures  greatly  reduce  NCDs  ?  
mainly  cancers,  cardiovascular  diseases,  diabetes  
and  chronic  respiratory  diseases  ?  that  accounted  
for  63%  of  all  deaths  worldwide  or  36  million  
people  in  2008(3).  
  
NCDs  are  the  leading  cause  of  death,  disease  and  
disability  and  account  for  nearly  86%  of  deaths  
and  77%  of  the  disease  burden  in  the  WHO  
European  Region  (4).  
  
Tobacco  is  the  most  preventable  cause  of  
death  and  diseases  and  can  be  successfully  
fought  by  means  of  a  comprehensive  set  of  
tobacco  control  measures.  
  
Effectiveness  of  tobacco  control  measures  need  to  
be  ensured  through  targeted  implementation  and  
intersectoral  actions.  
  
The  WHO  Framework  Convention  on  Tobacco  
Control  (WHO  FCTC)  (5),  the  cornerstone  for  
tobacco  control,  was  adopted  unanimously  by  the  
World  Health  Assembly  in  2003  and  today  counts  
177  Parties.  As  of  October  2013,  50  of  the  53  
Member  States  in  the  Region,  as  well  as  the  






The  WHO  FCTC  entered  into  force  on  27  February  
2005.  The  treaty  outlines  legally  binding  actions  
regarding  price  and  tax  measures  (Article  6);  non-­‐
price  measures  including  protection  from  smoke  
exposure  (Article  8);  packaging  and  labelling  
measures  (Article  11);  education,  communication,  
training  and  public  awareness  (Article  12);  
tobacco  advertising,  promotion  and  sponsorship  
bans  (Article  13);  and  demand  reduction  
measures  concerning  tobacco  dependence  and  
cessation  (Article  14)  (5).  
  
The  fight  against  tobacco  is  also  positively  
impacted  by  European  directives,  binding  28  of  
the  53  Member  States  in  the  Region  (7).  
  
In  the  EU,  some  of  the  major  directives  related  to  
tobacco  are:  
o Council  Directive  2011/64/EU  on  the  structure  
and  rates  of  excise  duty  applied  to  
manufactured  tobacco  (codification)  (8);  
o Directive  2001/37/EC  of  the  European  
Parliament  and  of  the  Council  of  5  June  2001  
on  the  approximation  of  the  laws,  regulations  
and  administrative  provisions  of  the  Member  
States  concerning  the  manufacture,  
presentation  and  sale  of  tobacco  products  (9).  
A  revision  of  the  Directive  has  been  
undertaken  to  adapt  to  recent  market,  




o Directive  2003/33/EC  of  the  European  
Parliament  and  of  the  Council  of  26  May  2003  
on  the  approximation  of  the  laws,  regulations  
and  administrative  provisions  of  the  Member  
States  relating  to  the  advertising  and  
sponsorship  of  tobacco  products  (13).  
  
Despite  tobacco  control  policies  that  are  
applicable  globally  (WHO  FCTC),  regionally  







The  European  Region  has   the  highest  prevalence  
of   tobacco   smoking   among   the   WHO   regions   at  








Fig.  1.  Smoking  prevalence  in  the  WHO  regions
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Tobacco  use  has  a  dramatic  impact  on  mortality  in  
Europe.  The  European  and  Americas  regions  have  
the  highest  mortality  attributed  to  tobacco  at  16%  
(Table  1).  
  
Table  1.  Proportion  of  all  deaths  attributed  to  
tobacco  in  the  WHO  regions  
  
WHO  region   Deaths  
attributed  to  
tobacco  (%)  
Europe   16  
Americas   16  
Western  Pacific   13  
South-­‐East  Asia   10  
Eastern  Mediterranean   7  
Africa   3  
Source:  WHO  global  report:  mortality  attributable  to  
tobacco  (15).  
  
Tobacco  kills  about  1.6  million  people  in  the  
Region;  more  than  25%  of  global  deaths  are  
attributed  to  tobacco.  Yet  the  Region  accounts  for  
only  14%  of  the  world  population  (16).  
  
Insufficient  implementation  of  tobacco  
control  measures  creates  gaps  and  loopholes  
for  the  tobacco  industry  to  exploit.  
  
Fighting  tobacco  effectively  calls  for  more  political  
intersectoral  support  and  courage;  it  takes  strong  
leaders  to  issue  strong  policies.  
  
Clear  and  specific  targets  have  been  defined  
to  support  and  scale  up  efforts  in  fighting  
tobacco  and  NCDs.  
  
The  Sixty-­‐sixth  World  Health  Assembly  adopted  
resolution  WHA  66.10  in  May  2013  on  the  global  
action  plan  for  the  prevention  and  control  of  
NCDs  2013?2020,  which  included  a  30%  reduction  
in  tobacco  use  by  2025  as  one  of  its  9  voluntary  












On  a  regional  level,  the  Region  has  developed  a  
health  policy  framework,  Health  2020,  laying  
down  a  strategic  path  and  a  set  of  priorities  on  
the  means  to  improve  health  (18).  One  of  the  four  
priorities  is  to  tackle  Europe?s  major  disease  
burden  from  NCDs,  including  tobacco.  
  
Ten  years  after  the  adoption  of  the  WHO  
FCTC,  it  is  time  to  look  back  and  take  stock  of  
the  situation  in  the  Region  in  order  to  
effectively  target  action  to  decrease  tobacco  
use  and  to  further  stimulate  the  increasing  
interest  on  endgame  strategies.  
  
Identifying  existing  gaps  in  tobacco  control  
measures  are  crucial  to  target  actions  needed  to  
decrease  and  stop  the  tobacco  epidemic.  
  
The  first  part  of  this  report  analyses  the  status  of  
various  WHO  FCTC  measures,  including  a  review  
of  the  progress  made  and  existing  gaps  in  the  
Region  and  in  relation  to  other  WHO  regions.  
  
The  analysis  is  based  on  data  that  have  been  
collected  and  validated  by  the  countries  for  the  
series  of  WHO  reports  on  the  global  tobacco  
epidemic  between  2007  and  2012  (19?22).  
  
The  second  part  of  this  report  explores  the  
concept  of  the  endgame  and  explores  three  
future  scenarios:  tobacco  as  a  legal  product,  as  a  
drug  and  as  a  commodity.  
  
Some  countries  in  the  Region  are  paving  the  way,  
regionally  and  globally,  for  others  to  consider  the  
endgame  in  their  tobacco  control  strategies,  
publicly  announcing  a  target  year  to  end  tobacco  
use  in  their  populations.  Nevertheless,  before  
considering  future  approaches,  many  countries  in  
the  Region  still  need  to  fully  implement  
comprehensive  tobacco  control  measures  as  the  
first  step  in  the  direction  of  a  tobacco  endgame.  
The  immediate  implementation  of  the  WHO  FCTC  





















Part  I  ?  WHO  FCTC  
implementation  status  
The  first  part  of  this  report  provides  an  analysis  
for  the  European  Region  of  the  implementation  
status  of  some  core  demand  reduction  provisions  
in  the  WHO  FCTC,  including  price  and  tax  
measures  (Article  6);  protection  from  exposure  to  
tobacco  smoke  (Article  8);  packaging  and  labelling  
of  tobacco  products  (Article  11);  education,  
communication,  training  and  public  awareness  
(Article  12);  tobacco  advertising,  promotion  and  
sponsorship  (TAPS)  (Article  13);  and  demand  
reduction  measures  concerning  tobacco  
dependence  and  cessation  (Article  14).  
  
Progress  and  gaps  in  the  implementation  of  the  
WHO  FCTC  measures  are  identified  and  reviewed  
from:  
-­‐  a  global  perspective,  providing  a  comparison  of  
the  European  Region  with  other  WHO  regions;  
-­‐  a  regional  perspective,  highlighting  main  trends,  
strengths  and  policy  gaps;  and  
-­‐  a  subregional  perspective,  providing  an  
intraregional  comparison  of  the  policy  status  
among  high  income  countries  (HICs)  and  low-­‐  and  
middle-­‐income  countries  (LMICs).1  
-­‐  Unless  otherwise  specified,  the  data  presented  
represent  the  period  2007?2012.  
                                                                                                                    
1  High-­‐income  countries  are:  Andorra,  Austria,  Belgium,  
Croatia,  Cyprus,  Czech  Republic,  Denmark,  Estonia,  
Finland,  France,  Germany,  Greece,  Hungary,  Iceland,  
Ireland,  Israel,  Italy,  Luxembourg,  Malta,  Monaco,  the  
Netherlands,  Norway,  Poland,  Portugal,  San  Marino,  
Slovakia,  Slovenia,  Spain,  Sweden,  Switzerland  and  the  
United  Kingdom.  
Middle-­‐income  countries  are:  Albania,  Armenia,  
Azerbaijan,  Belarus,  Bosnia  and  Herzegovina,  Bulgaria,  
Georgia,  Kazakhstan,  Latvia,  Lithuania,  Montenegro,  
Republic  of  Moldova,  Romania,  the  Russian  Federation,  
Serbia,  The  former  Yugoslav  Republic  of  Macedonia,  
Turkey,  Turkmenistan,  Ukraine  and  Uzbekistan.  
Low-­‐income  countries  are  Kyrgyzstan  and  Tajikistan.  
Since  only  two  European  countries  fall  into  the  
category  of  low-­‐income  countries,  the  categories  of  
LMICs  were  merged  and  compared  with  the  category  




















































A  summary  of  how  European  countries  are  
implementing  Article  6  of  the  WHO  FCTC  is  in    
Box  1.  
  
Price  and  tax  measures  are  an  important  
means  of  reducing  tobacco  consumption,  
especially  among  young  people.  
  
The  WHO  FCTC  therefore  encourages  each  Party  
to  adopt,  as  part  of  its  national  health  objectives  
for  tobacco  control,  appropriate  tax  and  price  
policies  on  tobacco  products  (Article  6).  
  
In  the  Region,  major  achievements  have  
been  realized  regarding  tax  measures.  
  
Raising  taxes  on  tobacco  products  is  one  of  the  
most  effective  ways  to  decrease  tobacco  use  (23,  
24).  
The  number  of  European  countries  where  taxes  
represent  more  than  75%  of  the  retail  price  of  the  
most  popular  brand  of  cigarettes2  has  increased  
from  15  in  2008  to  25  in  2012.This  corresponds  to  
an  increase  from  28%  to  47%  of  European  
countries.  
  
EU  legislation  has  contributed  significantly  to  
the  success  of  tax  measures.  
  
The  latest  piece  of  legislation,  Council  Directive  
2011/64/EU  of  21  June  2011  on  the  structure  and  
rates  of  excise  duty  applied  to  manufactured  
tobacco  (codification),  binds  EU  countries  to:  
  
-­‐ a  minimum  excise  duty  of  57%  of  the  retail  
selling  price  of  cigarettes  
-­‐ a  ???? ???????????????????????????????
cigarettes  regardless  of  the  retail  selling  price  
(8).  
  
HICs  record  excellent  results  within  the  
Region.  
  
In  2012,  61%  of  HICs  had  taxes  representing  more  
than  75%  of  the  retail  price,  compared  to  27%  of  
LMICs  for  a  regional  average  of  47%.  Although  
they  are  still  trailing  behind,  LMICs  have  
nevertheless  improved  significantly;  in  four  years,  
the  figure  rose  from  5%  in  2008  to  27%  in  2012.  
  
The  Region  has  not  only  made  important  
progress  over  the  years  but  is  also  doing  
better  than  all  other  WHO  regions.  
  
In  2012,  47%  of  countries  in  the  Region  (25  
countries)  had  tax  shares  representing  more  than  
75%  of  the  retail  price  of  the  most  popular  brand  






                                                                                                                    
2The  series  of  WHO  reports  on  the  global  tobacco  
epidemic  provide  four  categories  to  group  countries  
??????????????????????????????????????????????????????
???????????????????????????????????????????????????????????
the  highest  tax  shares  (19?22).  
Box  1.  Key  facts  
  
? The  WHO  European  region  is  doing  
better  than  all  other  WHO  Regions  
regarding  tax  measures  
  
? The  proportion  of  WHO  European  
countries  where  tax  represents  more  
than  75%  of  the  retail  price  of  the  
most  popular  brand  of  cigarettes  has  
increased  by  29%  between  2008  and  
2012  
  
? In  47%  of  the  WHO  European  
countries  more  than  75%  of  the  retail  
price  of  the  most  popular  brand  of  
cigarettes  is  tax.  
  
? The  WHO  European  region  records  a  
great  disparity  in  cigarette  retail  
prices  
  
? Different   types   of   tax   must   be  




Table  2.  Countries  with  tax  shares  representing  
more  than  75%  of  the  retail  price  of  the  most  




aFollowing  resolution  WHA66.21  adopted  during  the  
Sixty-­‐sixth  World  Health  Assembly  in  2013,  South  
Sudan  was  reassigned  from  the  Eastern  Mediterranean  
Region  to  the  African  Region.  Data  and  calculations  
used  for  this  report  cover  the  period  2007?2012  when  
South  Sudan  was  in  the  Eastern  Mediterranean  Region.  
  
Source:  Dataset  for  the  WHO  report  on  the  global  
tobacco  epidemic  2013  (14).  
  
However,  a  great  disparity  between  cigarette  
retail  prices  (CRPs)  persists  in  Europe.  
  
Data  collected  for  2012  show  that  the  retail  price  
for  the  most  sold  cigarettes  brand  (pack  of  20)  
ranges  from  Int$  1.02  (Kazakhstan)  to  Int$  10.56  
(Ireland).  
  
The  great  disparity  in  CRPs  within  the  Region,  
shown  in  Table  3,  raises  the  issue  of  cross-­‐border  
purchasing  and/or  illicit  trade.  
  
Table  3.  CRP  of  the  most  sold  brand  in  the  
European  Region,  2012  
  
CRP  (Int  $)  
Countriesa  
No.   %  
<  3   13   25  
3?5   15   28  
5?8   19   36  
<  8   3   6  
aData  not  available  for  Andorra,  Monaco  and  San  
Marino.  
Source:  Dataset  for  the  WHO  report  on  the  global  
tobacco  epidemic  2013  (14).  
  
This  is  particularly  true  where  great  disparities  in  
CRPs  exist  in  neighbouring  countries  as  it  does,  for  
example,  in:  
-­‐ Romania  (Int$  6.11)  and  Ukraine  (Int$  1.75)  or  
the  Republic  of  Moldova  (Int$  1.80)  
-­‐ Turkmenistan  (Int$  4.96)  and  Uzbekistan  
(Int$  1.80)  
-­‐ Bulgaria  (Int$  6.13)  and  The  former  Yugoslav  
Republic  of  Macedonia  (Int$  2.57)  
-­‐ Turkey  (Int$  4.89)  and  Georgia  (Int$  1.37).  
The  great  disparity  in  CRPs  does  not  
necessarily  result  from  different  tax  shares.  
  
It  is  important  to  note  that  there  is  no  systematic  
link  between  high  tax  share  and  high  CRP.  The  
final  tax  share  (including  all  applicable  taxes)  can  
be  similar  in  several  countries  having  very  
different  CRPs.  
  
For  example,  in  some  countries  where  about  80%  
of  the  retail  price  is  tax,  the  final  retail  price  
differs  considerably:  Int$  2.18  for  Montenegro,  
Int$  4.56  for  Slovenia,  Int$  4.89  for  Turkey,  
Int$  4.98  for  Finland,  Int$  6.78  for  France  and  
Int$  9.79  for  the  United  Kingdom.  
  
Combining  all  types  of  tax  undermines  the  
tobacco  industry  strategies.  
  
Different  types  of  tax  may  be  used  to  tax  tobacco  
products,  including  excise  duty  taxes  and  import  
duties  (both  applicable  to  selected  goods,  e.g.  
tobacco  products),  as  well  as  value-­‐added-­‐taxes  
and  sales  taxes  (both  applicable  to  all  goods).  
  
Ad  valorem  excise  taxes  can  significantly  impact  
the  retail  price;  the  higher  the  rate,  the  greater  
the  price  increase.  
  
However,  ad  valorem  excise  taxes  can  be  
undermined  by  the  tobacco  industry  by  setting  
low  retail  prices,  which  can  mitigate  the  impact  of  
a  high  tax  rate.  
  
On  the  contrary,  amount-­‐specific  excise  taxes  are  
not  calculated  in  reference  to  retail  price  but  
apply  per  stick,  per  pack,  per  1000  sticks,  or  per  
kilogram  (e.g.  Int$  1.75  per  pack  of  20  cigarettes);  
WHO  regiona  
Countries  
No.   %  
Europe   25   47  
Eastern  Mediterranean   3   13  
Americas   2   6  
Western  Pacific   1   4  
Africa   1   2  
South-­‐East  Asia   0   0  
14  
  
thus  the  tobacco  industry  cannot  influence  excise  
taxes  by  lowering  retail  prices.  
  
In  this  context,  it  is  important  to  note  that  
different  types  of  taxes  need  to  be  combined  to  
contribute  effectively  to  an  increase  of  the  retail  
price  thus  leading  to  a  decrease  in  tobacco  
consumption.  
  
While  price  and  tax  measures  are  a  cost-­‐effective  
way  to  reduce  tobacco  consumption,  they  should  
be  complemented  by  non-­‐price  measures,  
including  protection  from  exposure  to  tobacco  
smoke;  packaging  and  labelling  of  tobacco  
products;  education,  communication,  training  and  
public  awareness;  and  TAPS.  
  
Only  an  integrated  approach  can  be  fully  effective.  
  
     
15  
  
Article  8:  Europe  trailing  behind  
A  summary  of  how  European  countries  are  
implementing  Article  8  of  the  WHO  FCTC  is  





established  that  exposure  to  tobacco  smoke  
causes  death,  disease  and  disability?  (Article  
8.1  WHO  FCTC)  (5).  
  
To  protect  people  against  the  devastating  effect  
of  tobacco  smoke  on  health,  the  WHO  FCTC  
requires  each  Party  to  adopt  and  implement  
measures  providing  protection  from  exposure  to  
tobacco  smoke  in  indoor  workplaces,  public  
transport,  indoor  public  places  and,  as  
appropriate,  other  public  places.  
  
Guidelines  for  implementation  of  Article  8  were  
developed  to  assist  Parties  in  meeting  their  
obligations  and  to  identify  the  key  elements  of  
legislation  necessary  to  effectively  protect  people  
from  exposure  to  tobacco  smoke  (25).  
  
The  guidelines  strongly  recommend  the  adoption  
of  comprehensive  smoke-­‐free  legislation  within  
five  years  after  entry  into  force  of  the  WHO  FCTC.  
  
Some  progress  was  made  in  implementing  
comprehensive  smoking  bans.  
  
The  number  of  European  countries  banning  
smoking  in  all  public  places  has  increased  from  4  
countries  in  2007  to  9  (17%  of  European)  
countries  in  2012,  although  compliance  varies.3  
  
Despite  progress,  the  Region  still  provides  
less  protection  from  smoke  exposure  than  
most  WHO  regions.  
  
With  just  nine  of  its  countries  implementing  
smoking  bans  in  all  public  places,  the  European  
Region  ranks  second  to  last  among  WHO  regions,  
performing  better  than  only  the  African  Region  
(Table  4).  
  
Table  4.  Countries  implementing  smoking  bans  in  




No.   %  
Americas   14   40  
South-­‐East  Asia   3   27  
Western  Pacific   7   26  
Eastern  Mediterranean   5   22  
Europe   9   17  
Africa   5   11  
Source:  Dataset  for  the  WHO  report  on  the  global  
tobacco  epidemic  2013  (14).  
  
Progress  reducing  smoke  exposure  over  the  
last  years  has  been  uneven;  not  all  public  
places  were  equally  regulated.  
  
Between  2007  and  2012,  legislative  
improvements  regarding  the  scope  of  smoking  
                                                                                                                    
3  Albania,  Ireland,  Turkmenistan  and  the  United  
Kingdom  were  classified  as  smoke-­‐free  countries  in  
2007.  Turkey  became  smoke-­‐free  in  2008;  Greece,  
Malta  and  Spain  in  2010;  and  Bulgaria  in  2012.  (19?22).  
Box  2.  Key  facts  
  
? Only  nine  European  countries  ban  
smoking  in  all  public  places  and  
compliance  varies.  
  
? The  European  Region  lags  behind  
most  WHO  regions  regarding  
protection  from  smoke  exposure.  
  
? Protection  from  smoke  exposure  
remains  insufficient,  particularly  in  
government  facilities,  public  transport,  
restaurants,  pubs  and  bars,  and  indoor  
offices.  
  
? The  European  Region  is  doing  well,  
with  62%  of  countries  legislating  fines  




bans  were  made,  but  did  not  apply  to  the  same  
extent  to  all  categories  of  public  places.  
  
Improvements  were  particularly  significant  for  
schools,  universities,  government  facilities,  public  
transport,  restaurants,  pubs  and  bars.  The  
proportion  of  European  countries  banning  
smoking  in  each  of  these  places  was  about  20%  
higher  in  2012  than  in  2007.  
  
In  contrast,  progress  for  health  care  facilities  and  
indoor  offices  was  more  limited  for  the  same  
period  (2007?2012);  the  proportion  of  European  
countries  that  banned  smoking  in  health  care  
facilities  rose  by  only  15%  and  those  that  banned  
smoking  in  indoor  offices  by  just  10%.  
  
Protection  from  exposure  to  tobacco  smoke  
varies  greatly  depending  on  the  type  of  
public  places  (Fig.  3).  
  
In  2012,  32  European  countries  banned  smoking  
in  health  care  facilities,  32  banned  smoking  in  
universities  and  38  banned  smoking  in  schools.  
  
In  contrast,  other  public  places  such  as  
government  facilities,  public  transport,  pubs  and  
bars,  restaurants  and  indoor  offices  have  less  
coverage.  In  2012,  23  European  countries  banned  
smoking  in  government  facilities,  19  banned  
smoking  in  public  transport,  16  banned  smoking  in  
restaurants,  16  in  pubs  and  bars,  and  only  11  
banned  smoking  in  indoor  offices.  
  
  
Fig.  3.  Smoking  bans  in  public  places  in  the  European  Region,  2007?2012  
  
  











LMICs  generally  provide  more  protection  
from  exposure  to  tobacco  smoke  in  most  
public  places.  
  
LMICs  lead  the  way  banning  smoking  in  health  
care  facilities  and  universities  (73%);  government  
facilities  (50%);  and  pubs,  bars  and  restaurants  
(36%);  the  corresponding  figures  for  HICs  are  52%,  
39%  and  26%,  respectively  and  the  regional  
averages  are  60%,  43%  and  20%,  respectively.  
  
Most  countries  in  the  Region  have  legislation  
that  penalizes  smoking.  
  
Penalties  are  one  of  the  measures  to  ensure  high  
compliance  with  existing  policies.  
  
The  number  of  countries  in  the  Region  that  have  
legislation  penalizing  smoking  rose  from  35  in  
2007  to  49  in  2012,  which  represents  about  92%  
of  European  countries.  
  
The  most  noticeable  progress  was  made  in  the  
category  of  countries  imposing  fines  for  violation  
of  smoking  bans  on  both  the  establishment  and  
the  smoker  as  recommended  by  WHO  in  Article  8  
of  the  WHO  FCTC  (25).  The  number  of  countries  in  
this  category  has  increased  from  22  (42%)  to  33  
countries  (62%)  in  the  Region.  In  all  other  WHO  
regions,  the  corresponding  figures  range  from  
28%  in  the  African  Region  to  52%  in  the  Eastern  
Mediterranean  Region.    
  
HICs  are  doing  particularly  well  imposing  
extensive  fines.  
  
HICs  are  doing  very  well  imposing  fines  on  both  
the  establishment  and  the  smoker  (77%  of  HICs  
compared  to  41%  of  LMICs).  
  
In  contrast,  LMICs  appear  to  focus  only  on  the  
smoker.  Of  the  LMICs,  41%  impose  fines  only  on  




























Article  11:  more  to  be  done  
despite  progress  
A  summary  of  how  countries  in  the  Region  are  






Tobacco  consumption  can  be  reduced  by  
increasing  public  awareness  of  the  health  
effects  of  tobacco  use.  
  
The  WHO  FCTC  (Article  11)  provides  requirements  
regarding  the  packaging  and  labelling  of  tobacco  
products  to  be  implemented  within  three  years  
after  entry  into  force  of  the  Convention.  
  
Guidelines  for  implementation  of  Article  11  were  
developed  to  assist  Parties  in  meeting  their  
obligations  by  proposing  ways  to  increase  the  




Good  progress  has  been  made  regarding  the  
implementation  of  packaging  and  labelling  
requirements  for  tobacco  products  in  the  
Region.  
  
Fewer  European  countries  have  no  warnings  or  
small  warnings.  The  proportion  of  European  
countries  that  had  no  warnings  or  only  small  
warnings4  decreased  from  21%  (11  countries)  in  
2007  to  11%  (6  countries)  in  2012.  
  
In  2012,  32%  of  European  countries  had  medium  
size  warnings5  with  all  appropriate  characteristics6  
(or  large  warnings7  missing  some  appropriate  
characteristics),  which  is  an  increase  from  3  to  17  
countries.  
  
Improvements  regarding  the  provision  of  pictorial  
warnings  were  also  made.  The  proportion  of  
countries  requiring  pictorial  warnings  increased  
from  8%  (4  countries)  in  2007  to  38%  (20  
countries)  in  2012.  
  
The  ongoing  revision  of  the  Tobacco  
Products  Directive  (2001/37/EC)  highlights  
the  large  potential  and  opportunity  for  
advancement.  
  
The  2001  Tobacco  Products  Directive,  binding  EU  
countries,  provides  rules  concerning  the  
manufacture,  presentation  and  sale  of  tobacco  
products,  including,  for  example,  an  obligation  to  
display  health  warnings  on  tobacco  products  and  
comply  with  prescribed  requirements  about  their  
size,  format  and  other  characteristics  and  a  ban  
on  any  description  suggesting  that  a  product  (such  
as  ?light?)  is  less  harmful  than  others  (9).  
  
                                                                                                                    
4Average  of  front  and  back  of  package  is  less  than  30%.  
5  Average  of  front  and  back  of  package  is  between  30%  
and  49%.  
6  Appropriate  characteristics  are:  specific  health  
warnings  mandated;  appearing  on  individual  packages  
as  well  as  on  any  outside  packaging  and  labelling  used  
in  retail  sale;  describing  specific  harmful  effects  of  
tobacco  use  on  health;  are  large,  clear,  visible  and  
legible  (e.g.  specific  colours  and  font  style  and  sizes  are  
mandated);  rotate;  include  pictures  or  pictograms;  and  
written  in  (all)  the  principal  language(s)  of  the  country.  
7  Average  of  front  and  back  of  the  package  is  at  least  
50%.  
Box  3.  Key  facts  
  
? Fewer  European  countries  have  no  
warnings  or  small  warnings;  the  
proportion  of  countries  decreased  from  
21%  in  2007  to  11%  in  2012.  
  
? The  percentage  of  European  countries  
having  medium  size  warnings  with  all  
appropriate  characteristics  or  large  
warnings  missing  some  appropriate  
characteristics  increased  from  6%  in  
2007  to  32%  in  2012.  
  
? Only  4%  of  European  countries  have  
large  warnings  with  all  appropriate  
characteristics,  the  lowest  percentage  
among  all  regions.  
  
? Despite  a  30%  increase  in  the  number  of  
European  countries  mandating  pictorial  
warnings   from  2007   to   2012,  only   38%  
of  European  countries  required  pictorial  
warnings  in  2012.  
  




In  May  2005,  the  Commission  of  the  European  
Communities  adopted  a  library  of  42  colour  
photographs  and  other  illustrations  its  Member  
States  can  choose  from  to  strengthen  the  impact  
of  text  warnings  (Commission  Decision  C  (2005)  
1452  final)  (26).  
  
In  addition,  a  library  of  pictorial  warnings  is  
available  to  accompany  warning  messages  noting  
that  the  display  of  pictorial  warning  is  still  
voluntary  (27).  
  
A  revision  of  the  Directive  has  been  undertaken  to  
adapt  to  recent  market,  scientific  and  
international  developments.  Some  of  the  
proposals  discussed  relate  to  banning  cigarettes  
with  flavours,  the  regulation  of  electronic  
cigarettes,  the  increase  of  the  size  of  combined  
warnings  and  pictures,  and  the  voluntary  
introduction  of  plain  packaging  (10?12).  
  





While  efforts  undertaken  so  far  are  
encouraging,  evolving  market  strategies  of  
the  tobacco  industry  require  further  action  
to  reinforce  the  packaging  and  labelling  
requirements.  
  
In  2012,  only  two  countries  in  the  Region  required  
large  warnings  with  all  appropriate  characteristics  
(Table  5).8  In  contrast,  other  WHO  regions  have  
had  more  advancements  in  this  area,  particularly  
the  Americas.  
  
Table  5.  Countries  requiring  large  warnings  with  
all  appropriate  characteristics  on  tobacco  




No.   %  
Americas   12   34  
South-­‐East  Asia   3   27  
Western  Pacific   6   22  
Eastern  Mediterranean   3   13  
Africa   4   9  
Europe   2   4  
Source:  Dataset  for  the  WHO  report  on  the  global  
tobacco  epidemic  2013  (14).  
  
Not  all  packaging  and  labelling  
characteristics  are  equally  covered  by  the  
law.  
  
Some  packaging  and  labelling  characteristics  are  
insufficiently  regulated.  Of  the  European  
countries,  38%  (20  countries)  have  implemented  
picture  warnings,  27%  (9  countries)  require  quit  
lines  on  all  packaging  or  labelling  (if  the  country  
has  a  quit  line),  4%  (2  countries)  require  warnings  
placed  at  the  top  of  the  principal  display  area,  and  
2%  (1  country)  mandate  qualitative  information  
on  constituents/emissions.  
  
Some  packaging  and  labelling  requirements  are  
completely  missing  in  European  countries.  This  is  
the  case  for:  bans  on  expiry  dates  being  displayed  
on  the  package,  warnings  not  removing  or  
diminishing  the  liability  of  the  tobacco  industry,  
bans  on  packaging  and  labelling  using  descriptors  
depicting  flavours,  and  bans  on  display  of  






                                                                                                                    




HICs  generally  have  broader  regulations  on  
tobacco  packaging  and  labelling.  
  
Disparities  exist  between  HICs  and  LMICs  
regarding  the  regulation  of  some  tobacco  
packaging  and  labelling  requirements.  
  
For  example,  more  HICs  (90%)  than  LMICs  (77%)  
ban  the  use  of  deceitful  terms  on  cigarette  
packaging  for  a  regional  average  of  85%.  
  
Similarly,  more  HICs  (87%)  than  LMICs  (68%)  
require  display  warnings  on  individual  packages  
and  on  any  outside  packaging  and  labelling  used  
in  retail  sale  for  a  regional  average  of  79%.  
  
The  difference  is  even  greater  with  81%  of  HICs  
requiring  display  warnings  on  all  tobacco  products  
whether  manufactured  domestically,  imported  or  
for  duty  free  sale  compared  to  55%  of  LMICs,  with  
a  regional  average  of  70%.  
  
Finally,  more  than  twice  as  many  HICs  (87%)  than  
LMICs  (41%)  ban  cigarette  substitutes  for  using  
misleading  terms,  with  a  regional  average  of  68%.  
  
Not  all  tobacco  products  are  uniformly  
regulated.  The  labelling  and  packaging  
requirements  are  better  for  cigarettes  than  
other  forms  of  tobacco.  
  
Packaging  and  labelling  of  tobacco  products  other  
than  cigarettes  (i.e.  other  smoked  tobacco  and  
smokeless  tobacco)  are  less  regulated  than  
cigarettes  in  general  and  smokeless  tobacco  in  
particular.  
  
For  example,  in  the  Region,  pictorial  health  
warnings  are  required  for  cigarettes  in  20  
countries,  for  other  smoked  tobacco  in  19  
countries  and  for  smokeless  tobacco  in  only  seven  
countries.  
  
The  difference  is  even  greater  for  the  
characteristic  ?rotating  health  warnings?  required  
for  cigarettes  in  47  countries,  for  other  smoked  
tobacco  in  45  countries  and  for  smokeless  tobacco  





























Article  12:  need  to  implement  
effective  campaigns  
A  summary  of  how  European  countries  are  






?Each  Party  shall  promote  and  strengthen  
public  awareness  of  tobacco  control  issues?  
(Article  12  WHO  FCTC)  (5).  
  
Campaigns  play  a  key  role  provided  that  they  are  
designed  in  a  way  that  makes  them  effective  (see  
Box  5).  Only  campaigns  with  duration  of  at  least  
three  weeks  and  conducted  between  January  
2011  and  June  2012  were  considered  for  analysis.  
  
The  number  of  effective  anti-­‐tobacco  mass  
media  campaigns  is  limited.  
  
The  number  of  European  countries  that  
conducted  a  national  campaign  with  at  least  
seven  appropriate  characteristics  including  airing  
on  television  and/or  radio  decreased  from  14  
(26%  of  countries  in  the  Region)  in  2010  to  8  
(15%)  in  2012.9  
  
Only  the  African  Region  had  a  lower  proportion  
than  the  European  Region  as  shown  in  Table  6.  
  
  
                                                                                                                    
9  The  countries  are  Belarus,  Georgia,  Luxembourg,  
Norway,  the  Russian  Federation,  Switzerland,  Turkey  
and  the  United  Kingdom.  
Box  5.  Mass  media  campaign  
characteristics  
Characteristics  used  to  review  European  
?????????????????????????????????? ??  
reports  on  the  global  tobacco  epidemic.  
  
1.  The  campaign  was  part  of  a  comprehensive  
tobacco  control  programme.  
2.  Before  the  campaign,  research  was  
undertaken  or  reviewed  to  gain  a  thorough  
understanding  of  the  target  audience.  
3.  Campaign  communications  materials  were  
pretested  with  the  target  audience  and  
refined  in  line  with  campaign  objectives.  
4.  Air  time  (radio,  television)  and/or  
placement  (billboards,  print  advertising,  etc.)  
was  purchased  or  secured.  
5.  The  implementing  agency  worked  with  
journalists  to  gain  publicity  or  news  coverage  
for  the  campaign.  
6.  Process  evaluation  was  undertaken  to  
assess  how  effectively  the  campaign  hadbeen  
implemented.  
7.  An  outcome  evaluation  process  was  
implemented  to  assess  campaign  impact.  
8.  The  campaign  was  aired  on  television  
and/or  radio.  
? Source:  WHO  report  on  the  global  tobacco  
epidemic,  2013:  enforcing  bans  on  tobacco  
advertising,  promotion  and  sponsorship  (22).  
Box  4.  Key  facts  
  
? The  proportion  of  European  countries  
that  conducted  national  campaigns  with  
at  least  seven  appropriate  characteristics  
including  airing  on  television  and/or  
radio  was  26%  in  2010.  
  
? In  2012,  only  15%  of  European  countries  
conducted  national  campaigns  with  at  
least  seven  appropriate  characteristics  
including  airing  on  television  and/or  
radio,  compared  to  the  South-­‐East  Asia  
(27%)  and  Western  Pacific  (37%)  regions.  
  
? Forty-­‐two  per  cent  of  European  
countries  have  not  conducted  a  national  
campaign  between  January  2011  and  




Table  6.  Countries  conducting  a  national  
campaign  with  at  least  seven  appropriate  
characteristics  including  airing  on  television  




No.   %  
Western  Pacific   10   37  
South-­‐East  Asia   3   27  
Americas   6   17  
Eastern  Mediterranean   4   17  
Europe   8   15  
Africa   6   13  
Source:  Dataset  for  the  WHO  report  on  the  global  
tobacco  epidemic  2013  (14).  
  
LMICs  show  continuity  in  the  number  of  
effective  anti-­‐tobacco  mass  media  
campaigns.  
  
The  proportion  of  HICs  conducting  anti-­‐tobacco  
mass  media  campaigns  with  at  least  seven  
appropriate  characteristics,  including  airing  on  
television  and/or  radio,  declined  from  32%  in  
2010  to  13%  in  2012;  the  figure  for  LMICs  held  
steady  at  18%  during  this  period.  
  
Almost  half  of  the  European  countries  have  
not  conducted  national  campaigns  of  at  least  
three  weeks  in  duration  between  January  
2011  and  June  2012.  
  
With  42%  of  its  countries  not  organizing  a  national  
campaign  lasting  at  least  three  weeks,  the  
European  Region  ranks  second  to  last  among  
WHO  regions,  performing  better  than  only  the  
South-­‐East  Asia  Region  at  27%.  The  corresponding  
figures  for  the  African,  Americas,  Eastern  
Mediterranean  and  Western  Pacific  regions  were:  





























Article  13:  Europe  failing  to  
prohibit  all  indirect  forms  of  TAPS  
A  summary  of  how  European  countries  are  









The  adoption  of  a  comprehensive  ban  on  
TAPS  is  essential  to  reduce  tobacco  use  
(Article  13.1  WHO  FCTC)  (5).  
  
The  WHO  FCTC  requires  the  Parties  to  adopt,  
within  a  period  of  five  years  after  entry  into  force,  
a  comprehensive  ban  on  all  forms  of  TAPS,  
whether  direct  or  indirect,  that  aim  to  have  the  
effect  or  likely  effect  of  promoting  a  tobacco  
product  or  tobacco  use  (5).  
  
Guidelines  for  implementation  of  Article  13  were  
developed  to  assist  Parties  in  meeting  their  
obligations  by  giving  Parties  guidance  for  
introducing  and  enforcing  a  comprehensive  ban  
on  TAPS  (25).  
  
To  date,  few  European  countries  have  
adopted  comprehensive  bans  on  TAPS.  
  
In  2012,  only  three  European  countries10  
(representing  about  6%  of  European  countries)  
had  adopted  a  comprehensive  ban  covering  all  
forms  of  direct  and  indirect  advertising.11  
  
The  European  Region  did  not  improve  at  the  
same  rate  as  other  WHO  regions  regarding  
the  implementation  of  comprehensive  bans  
on  TAPS.  
  
With  2%  of  its  countries  (one  country)  applying  a  
comprehensive  ban  on  TAPS  in  2007,  the  
European  Region  ranked  third  among  WHO  
regions,  behind  the  Eastern  Mediterranean  
Region  at  14%  and  the  African  Region  at  9%.  No  
                                                                                                                    
10The  countries  are  Albania  (in  2007  already  
categorized  as  a  country  implementing  a  
comprehensive  ban  on  all  TAPS),  Spain  (since  2010)  
and  Turkey  (since  2012).  
11  Direct  forms  of  TAPS  used  for  analysis  are:  
advertising  on  national  television  and  radio,  in  local  
magazines  and  newspapers,  on  billboards  and  outdoor  
advertising  and  at  points  of  sale.  
Indirect  forms  of  TAPS  are:  free  distribution  of  tobacco  
products,  promotional  discounts,  non-­‐tobacco  
products  identified  with  tobacco  brand  names  (brand  
stretching),  brand  names  of  non-­‐tobacco  products  used  
for  tobacco  products  (brand  sharing)  appearance  of  
tobacco  brands  or  products  in  television  and/or  films  
(product  placement),  and  sponsored  events  (including  
corporate  social  responsibility  programmes).  
Box  6.  Key  facts  
  
 The  European  Region  lags  behind  all  
other  WHO  regions  in  implementing  
comprehensive  bans  on  TAPS.  
  
 Regulation  of  bans  on  direct  forms  of  
TAPS  is  generally  satisfactory  but  greater  
efforts  are  needed  to  implement  bans  on  
indirect  forms  of  TAPS.  
  
 The  most  common  bans  on  TAPS  
concern:  national  television  and  radio,  
local  magazines  and  newspapers,  
billboards  and  outdoor  advertising,  
international  television  and  radio,  
Internet,  product  placement,  free  
distribution  of  tobacco  products,  vending  
machines,  sponsored  events  and  
promotional  discounts.  
  
 The  least  regulated  forms  of  TAPS  are  
indirect  and  include  brand  stretching,  
brand  sharing,  showing  tobacco  products  
in  television  and/or  films,  publicizing  
corporate  social  responsibility  (CSR)  and  




country  in  the  other  three  WHO  regions  
implemented  a  comprehensive  ban.  
  
Between  2007  and  2012,  the  number  of  European  
countries  applying  a  comprehensive  ban  has  
increased  from  one  in  2007  to  three  in  2012  
(Table  7).  
  
Table7.  Number  of  countries  applying  
comprehensive  TAPS  bans  in  the  WHO  regions  
from  2007  to  2012  
  
Source:  Dataset  for  the  WHO  report  on  the  global  
tobacco  epidemic  2013  (14).  
  
While  the  European  Region  lags  behind  in  
implementing  comprehensive  bans  on  TAPS,  
it  nevertheless  records  very  good  results  in  
regulating  some  forms  of  TAPS.  
  
This  is  particularly  true  for  the  direct  forms  of  
TAPS.  
European  countries  have  widely  adopted  bans  on  
tobacco  advertising  and  promotion  on  national  
television  and  radio  (50  countries),  local  
magazines  and  newspapers  (45  countries),  
billboards  and  outdoor  advertising  (43  countries)  
and  international  television  and  radio  (43  
countries)  (Fig.  4).  
  
Some  indirect  forms  of  TAPS  are  also  banned  in  a  
majority  of  the  countries,  such  as  product  
placement  (39  countries),  distribution  of  free  
tobacco  products  (35  countries),  tobacco  vending  
machines  (30  countries)  and  promotional  
discounts  (29  countries).  While  29  countries  in  the  
Region  ban  the  sponsorship  of  events  by  the  
tobacco  industry,  only  three  countries  ban  CSR  
initiatives  that  publicize  the  tobacco  industry  or  its  
products.  
  
A  majority  of  European  countries  regulate  some  
indirect  forms  of  TAPS,  such  as  product  
placement,  distribution  of  free  tobacco  products,  
tobacco  vending  machines,  sponsorship  of  events  



























No.  of  countries  
2007   2012  
Africa   4   9  
Americas   0   3  
South-­‐East  Asia   0   1  
Europe   1   3  
Eastern  Mediterranean   3   5  













EU  directives,  binding  the  EU  countries,  have  
contributed  to  these  good  results.  
  
Directive  2003/33/EC,  on  the  advertising  and  
sponsorship  of  tobacco  products,  prescribes  the  
adoption  of  a  ban  on  all  forms  of  tobacco  
advertising  and  promotion  in  printed  media,  on  
radio  and  on  Internet.  It  also  prohibits  
sponsorship  of  international  events  by  the  
tobacco  industry  together  with  the  distribution  of  
free  tobacco  products  during  international  
sponsored  events  (13).  
  
The  Audiovisual  Media  Services  Directive  
(2007/65/EC)  bans  tobacco  advertising  and  
sponsorship  in  all  forms  of  audiovisual  commercial  
communications  including  product  placement  
(28).  
  
Between  2007  and  2012,  improvements  
were  noticeable  particularly  for  the  
regulation  of  some  TAPS.  
  
The  proportion  of  European  countries  banning  
product  placement  of  tobacco  and  tobacco  
products  has  increased  by  25%  between  2007  and  
2012  from  26  to  39  countries.  
  
Bans  on  tobacco  advertising  and  promotion  in  the  





Similarly,  between  2007  and  2012,  nine  additional  
European  countries  (representing  about  17%  of  
European  countries)  have  adopted  bans  on  
tobacco  vending  machines,  bringing  the  
proportion  of  European  countries  banning  
tobacco  vending  machines  in  2012  to  57%.  
  
The  Region  leads  globally  in  banning  some  
forms  of  direct/indirect  advertising.  
  
The  Region  had  the  strongest  TAPS  regulations12  
in  place  in  2012  in  some  forms  of  tobacco  
advertising  (Table  8).  
  
Table  8.  Countries  banning  tobacco  advertising  
on  national  television,  radio,  print  media  and  on  





No.   %  
Europe   42   79  
Western  Pacific   18   67  
South-­‐East  Asia   7   64  
Eastern  Mediterranean   13   57  
Africa   14   30  
Americas   9   26  
Source:  Dataset  for  the  WHO  report  on  the  global  
tobacco  epidemic  2013  (14).  
  
While  some  forms  of  direct  TAPS  are  
insufficiently  regulated  within  the  Region,  
much  larger  gaps  exist  in  regulating  indirect  
forms  of  TAPS.  
  
Regulating  tobacco  advertising  in  international  
magazines  and  newspapers  and  at  points  of  sale  
remains  limited.  Of  the  European  countries,  only  
                                                                                                                    
12  In  the  series  of  WHO  reports  on  the  global  tobacco  
epidemic,  four  different  categories  are  used  to  classify  








that  does  not  cover  national  TV,  radio  ?????????? ??????
(19?22).  
21  (40%)  adopted  a  ban  in  international  
magazines  and  newspapers  and  just  19  (36%)  at  
points  of  sale.  
  
Table  9  shows  the  main  gaps  that  exist  in  
regulating  indirect  forms  of  TAPS  in  the  Region.  
  
Table  9.  Countries  banning  indirect  forms  of  
TAPS  in  the  European  Region,  2012  
  
Bans  on  indirect  forms  of  TAPS  
Countries  
No.   %  
Brand  stretching   17   32  
Brand  sharing   13   25  
Appearance  of  tobacco  
products  in  television  and/or  
films  
12   23  
Publicizing  CSR  by  tobacco  
entities  and  by  non-­‐tobacco  
entities  
3   6  
Tobacco  company  contributions  
to  prevention  media  campaigns  
3   6  
Required  anti-­‐tobacco  ads  in  
media  depicting  tobacco  
products,  use  or  images  
1   2  
Source:  Dataset  for  the  WHO  report  on  the  global  










LMICs  are  doing  particularly  well  regulating  
tobacco  vending  machines,  which  are  banned  in  
91%  of  LMICs  compared  to  32%  of  HICs.  
  
Similarly,  international  forms  of  tobacco  
advertising  are  better  regulated  in  LMICs.  More  
LMICs  (86%)  than  HICs  (77%)  ban  tobacco  
advertising  on  international  television  and  radio.  
More  LMICs  (59%)  than  HICs  (26%)  ban  tobacco  
advertising  in  international  magazines  and  
newspapers.  
  
However,  LMICs  need  to  strengthen  their  efforts.  
More  HICs  (71%)  than  LMICs  (59%)  ban  the  free  
distribution  of  tobacco  products.  Similarly,  more  





























Article  14:  Despite  improvements  
providing  cessation  services,  more  
efforts  are  needed  
A  summary  of  how  European  countries  are  





?????????????????? take  effective  measures  
to  promote  cessation  of  tobacco  use  and  
adequate  treatment  for  tobacco  
dependence?  (Article  14  WHO  FCTC)  (5).  
  
Guidelines  for  implementation  of  Article  14  were  
developed  to  assist  Parties  in  meeting  their  
obligations  by  identifying  key  effective  measures  
needed  to  promote  tobacco  cessation  and  
incorporate  tobacco  dependence  treatment  into  
national  tobacco  control  programmes  and  
healthcare  systems.  
  
The  guidelines  highlight  the  importance  of  
promoting  tobacco  cessation  and  treatment  of  
tobacco  dependence  as  key  elements  of  a  
comprehensive,  integrated  tobacco  control  
program.  ?Support  for  tobacco  users  in  their  
cessation  efforts  and  successful  treatment  of  their  
tobacco  dependence  will  reinforce  other  tobacco  
control  policies,  by  increasing  social  support  for  
them  and  increasing  their  acceptability?(25).  
  
The  Region  has  progressed  slowly  in  
providing  comprehensive  cessation  services.  
  
In  2012,  only  13%13  of  European  countries  
operated  a  national  quit  line  and  provided  cost  
coverage  for  both  NRT  and  some  cessation  
services  compared  to  8%  in  2007.  In  this  regard,  
the  European  Region  is  average  compared  to  
other  WHO  regions  (Table  10  and  Fig.  5).  
  
Table  10.  Countries  providing  a  national  quit  line  
and  both  nicotine  NRT  and  some  cessation  




No.   %  
Americas   6   17  
Western  Pacific   4   15  
Europe   7   13  
Eastern  Mediterranean   3   13  
South-­‐East  Asia   1   9  
Africa   0   0  
Source:  Dataset  for  the  WHO  report  on  the  global  
tobacco  epidemic  2013  (14)
                                                                                                                    
13  The  countries  are  Denmark,  France,  Ireland,  Israel,  
Romania,  Turkey  and  the  United  Kingdom.  
Box  7.  Key  facts  
  
 The  proportion  of  European  countries  
operating  a  national  quit  line  and  
providing  cost  coverage  for  both  
nicotine  replacement  therapy  (NRT)  and  
some  cessation  services  has  increased  
by  5%  from  four  to  seven  countries  
between  2007  and  2012.  
  
 Of  the  European  countries,  68%  offer  
NRT  and/or  some  cessation  services  (at  
least  one  of  which  is  cost-­‐covered)  in  
2012  compared  to  42%  in  2007.  
  
 Globally,  the  Region  is  average  
regarding  the  provision  of  a  national  
quit  line  and  providing  cost  coverage  for  
both  NRTs  and  some  cessation  services  
but  excels  regarding  the  provision  of  
NRT  and/or  some  cessation  services  (at  
least  one  of  which  is  cost-­‐covered).  
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Fig.  5.  Distribution  of  cessation  services  and/or  medications  offered  across  WHO  regions  
  
  
Source:  WHO  report  on  the  global  tobacco  epidemic,  2011:  warning  about  the  dangers  of  tobacco  (21).  
  
In  contrast,  the  Region  improved  greatly  in  
providing  NRT  and/or  some  cessation  
services  (at  least  one  of  which  is  cost-­‐
covered).  
  
The  number  of  European  countries  offering  NRT  
and/or  some  cessation  services  (at  least  one  of  
which  is  cost-­‐covered)  has  increased  from  22  in  
2007  to  36  in  2012.  
  
In  this  regard,  the  European  Region  leads  the  way  







Table  11.  Countries  offering  NRT  and/or  some  
cessation  services  (at  least  one  of  which  is  cost-­‐




No.   %  
Europe   36   68  
Western  Pacific   14   52  
Americas   15   43  
Eastern  Mediterranean   9   39  
Africa   13   28  
South-­‐East  Asia   2   18  
Source:  Dataset  for  the  WHO  report  on  the  global  












































National  quit  line,  and  both  
NRT  and  some  cessation  
services  cost-­‐covered  
NRT  and/or  some  cessation  
services  (at  least  one  of  which  
is  cost-­‐covered)  
Nicotine  replacement  therapies  
(NRT)  and/or  some  cessation  
services  (neither  cost-­‐covered)  
None  
Data  not  reported  
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Quit  lines  are  more  broadly  implemented  in  
HICs.  
  
In  2012,  77%  of  HICs  in  the  Region  had  a  national  
quit  line  compared  to  41%  of  LMICs.  
  
Conclusion  
The  WHO  FCTC  is  a  powerful  legal  instrument  to  
help  tackle  the  tobacco  epidemic.  Momentum  is  
growing  and  more  governments  are  taking  strong  
measures.  
  
Since  the  WHO  FCTC  adoption  10  years  ago,  there  
has  been  good  progress  made  in  the  Region,  
signifying  commitment  to  combat  tobacco,  while  
at  the  same  time,  progress  regarding  tobacco  
control  policies  has  been  quite  disparate.  A  heat  
map  depicting  the  regional  summary  of  the  
implementation  of  measures  within  the  WHO  
FCTC  is  shown  in  Annex  1.  
  
The  most  significant  advancement  has  been  made  
regarding  tax  measures  (Article  6).  In  2012,  with  
47%  of  its  countries  providing  strong  tax  measures  
(tax  representing  at  least  75%  of  the  CRP),  the  
Region  provided  a  positive  role  model  for  all  other  
WHO  regions.  
  
HICs  in  the  Region  have  been  doing  particularly  
well  with  61%  of  them  providing  strong  tax  
measures,  compared  to  27%  of  LMICs.  
  
Still,  the  persistence  of  great  disparities  in  CRPs  
raises  the  issue  of  cross-­‐border  sales  and  illicit  
trades  and  calls  for  stronger  action  in  the  Region.  
To  date  (as  of  31  October  2013),  10  WHO  FCTC  
Parties  from  the  Region  have  signed  the  Protocol  
to  Eliminate  Illicit  Trade  in  Tobacco  Products  ?  
Belgium,  Cyprus,  Finland,  France,  Germany,  
Greece,  Lithuania,  Montenegro,  Norway  and  
Turkey(29).  
  
While  the  Region  shows  good  results  regarding  
the  implementation  of  Article  6,  important  efforts  
need  to  be  made  regarding  the  implementation  of  
non-­‐price  measures.  
  
Progress  regarding  the  regulation  of  exposure  to  
tobacco  smoke  (Article  8)  has  been  too  limited.  
Not  only  is  the  number  of  European  countries  
implementing  a  comprehensive  smoking  ban  too  
low,  the  problem  of  non-­‐compliance  arises  as  
well.  
  
Protection  from  exposure  to  tobacco  smoke  has  
not  advanced  quickly  enough  and  remains  
significantly  insufficient  in  government  facilities,  
public  transport,  restaurants,  pubs  and  bars,  and  
indoor  offices,  although  LMICs  lead  the  way  
regarding  banning  smoking  in  public  places,  such  
as  health  care  facilities,  universities,  government  
facilities,  pubs  and  bars,  and  restaurants.  
  
Achievements  regarding  penalties  for  violation  of  
smoking  bans,  especially  in  HICs  (of  which  77%  
provide  fines  on  both  the  smoker  and  the  
establishment)  are  very  encouraging  and  
exemplary  but  must  be  strengthened  towards  
comprehensive  smoking  bans  in  the  Region.  
Some  progress  regarding  the  regulation  of  
tobacco  packaging  and  labelling  (Article  11)  has  
been  made  within  the  Region  with,  for  example,  
an  increase  in  the  proportion  of  countries  
providing  pictorial  warnings  (8%  in  2007  
compared  to  38%  in  2012)  or  an  increase  in  the  
percentage  of  countries  with  medium  size  
warnings  with  all  appropriate  characteristics  or  
large  warnings  missing  some  appropriate  
characteristics  (6%  in  2007  to  32%  in  2012).  In  
general,  HICs  led  in  the  implementation  of  
packaging  and  labelling  requirements.  
  
However,  stronger  action  is  needed  to  adapt  to  
evolving  tobacco  industry  marketing  strategies  
and  new  tobacco  products.  European  countries  
need,  for  example,  to  regulate  further  smokeless  
tobacco  products,  adopt  more  broadly  pictorial  
warnings,  expand  further  the  size  of  health  
warnings,  ban  packaging  and  labelling  using  
descriptors  depicting  flavours,  and  require  
national  quit  line  numbers  on  packages.  
  
The  Tobacco  Products  Directive  (2001/37/EC)  
includes  an  obligation  to  display  health  warnings  
on  tobacco  products  and  comply  with  prescribed  
requirements  about  their  size,  format  and  other  
characteristics,  among  other  regulations  (9).  The  
Directive  is  currently  being  revised  with  a  
proposed  increase  of  the  size  of  combined  text  
and  picture  warnings.  The  revision  represents  an  
opportunity  to  advance  good  practices  in  tobacco  
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packaging  and  labelling  in  the  EU  countries  and  
beyond.  
  
In  addition,  comprehensive  bans  on  TAPS  should  
be  expanded  to  encompass  all  forms  of  TAPS  as  
prescribed  by  Article  13.  
  
While  direct  forms  of  TAPS  are  well  covered  
within  the  Region,  the  regulation  of  indirect  forms  
of  TAPS  needs  to  be  strengthened  considerably  to  
encompass,  for  example,  advertising  at  points  of  
sale,  brand-­‐stretching,  brand-­‐sharing  orCSR.  
  
LMICs  have  notably  stronger  bans  than  HICs  on  
various  specific  forms  of  TAPS  such  as  banning  
tobacco  vending  machines  and  banning  
advertisement  in  international  
magazines/newspapers  and  international  
television/radio.  
Finally,  the  Region  needs  to  keep  up  its  efforts  
towards  the  development  of  cessation  services  
and  tobacco  dependence  treatment.  In  2012,  
while  68%  of  the  European  countries  provide  NRT  
and/or  some  cessation  services  (at  least  one  of  
which  is  cost-­‐covered),  only  13%  of  European  
countries  provided  a  national  quit  line  along  with  
both  NRT  and  cost-­‐coverage  of  some  cessation  
services.  
  
Only  a  comprehensive  approach  to  tobacco  
control  can  effectively  stem  and/or  eliminate  the  
tobacco  epidemic  and  help  realize  the  voluntary  
global  NCD  target  for  a  30%  reduction  of  tobacco  
use  by  2025.  
  
However,  only  a  few  countries  in  the  Region  have  
taken  such  a  comprehensive  approach.  
Preliminary  projections  into  2025  reveal  that  
stronger  action  in  comprehensive  
implementation  of  the  WHO  FCTC  in  the  Region  
needs  to  be  taken  to  meet  the  global  target.  
  
One  of  the  primary  challenges  that  Parties  in  the  
Region  have  identified  in  the  Conference  of  
Parties  reports  is  lack  of  political  will.  Nothing  
shows  more  political  will  than  countries  that  have  
approached  the  WHO  FCTC  comprehensively  and  
have  been  inspired  from  it  to  even  go  beyond,  
contemplating  standardized  packaging  and  
indicating  plans  to  even  exceed  the  voluntary  
global  target  by  considering  the  endgame  of  
tobacco.  
  
A  strong  and  comprehensive  approach  to  the  
WHO  FCTC  has  shown  that  tough  laws  work  ?  
therein  lies  the  key  to  saving  lives.  
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Part  II  ?  The  vision  for  
an  endgame  
Part  I  of  the  report  shows  that  although  most  
Member  States  in  the  Region  and  the  EU  are  
legally  bound  to  the  WHO  FCTC,14  and  despite  
visibly  advancing  in  the  implementation  of  
tobacco  control  measures,  many  countries  in  the  
Region  still  lack  mechanisms  to  address  or  
properly  enforce  the  core  provisions  outlined  in  
the  treaty,  even  after  almost  a  decade  of  its  
entering  into  force.  Besides  competing  priorities  
and  reported  political  inattention,  many  still  
consider  confronting  the  tobacco  epidemic  as  a  
health  sector?s  responsibility  and  part  of  the  
problem  may  be  lack  of  consideration  given  to  the  
issue  by  non-­‐health  sectors.  Furthermore,  as  in  
the  rest  of  the  world,  the  tobacco  industry??  
strong  presence  in  the  Region  poses  a  threat  to  
effectively  implementing  further  tobacco  control  
measures.  
  
The  success  of  some  countries  in  the  Region  in  
implementing  comprehensive  tobacco  control  
policies  is  evident  with  a  sharp  reduction  in  
smoking  prevalence.  A  natural  next  step  for  these  
countries  and  for  their  followers  is  the  increased  
interest  on  what  are  coined  ?endgame?  strategies.  
This  discussion  has  only  been  reflected  in  the  
political  agenda  or  national  tobacco  control  
strategies  in  the  last  four  years,  with  the  
exception  of  Bhutan  who  banned  the  sale  of  
tobacco  products  in  2004  (30).  
  
But  what  does  endgame  mean?  The  expression  
comes  from  chess  and  chess-­‐like  games,  where  
the  endgame  (or  end  game  or  ending)  is  defined  
as  the  stage  of  the  game  when  there  are  few  
pieces  left  on  the  board  (31).  By  analogy,  some  
governments  have  outlined  a  strategic  plan  to  
further  reduce  tobacco  prevalence  to  a  defined  
low  level  ?  usually  close  to  zero  ?  within  a  set  
period  using  the  ?tobacco  endgame?  approach.  
The  strategic  plan  may  grant  or  not  exceptions  to  
products  such  as  smokeless  tobacco  electronic  
nicotine  delivery  systems  (ENDS).  
  
                                                                                                                    
14Tajikistan  was  the  177th  country  in  the  world  and  the  
50th  country  in  the  European  Region  to  become  a  
Party  to  the  WHO  FCTC  (6).  
Strategies  that  can  result  in  an  endgame  consider  
tobacco  as  a  systemic  ?  as  opposed  to  an  
individual  behaviour  ?  issue,  go  beyond  the  
demand  reduction  measures  by  addressing,  with  
priority,  the  supply  side,  and  involve  a  
fundamental  de-­‐normalization  not  just  of  tobacco  
use,  but  of  the  tobacco  industry,  by  removing  
profitability  and  by  making  the  industry  liable  
(32,33).  Furthermore,  a  focus  on  disadvantaged  
groups  and  policy  action  with  tobacco  control  
address  the  wider  social  determinants  of  
inequalities  and  health.  
  
While  countries  in  the  Region  are  expressing  
interest  in  the  matter,  a  firm  commitment  to  a  
tobacco  endgame  was  already  made  by  Finland,  
Ireland  and  the  United  Kingdom  (Scotland)  who  
have  publicly  announced  a  target  year  to  end  
tobacco  use  in  their  populations.  These  countries  
are  committed  to  decrease  tobacco  use  to  below  
5%  by  the  target  year.  
  
In  2010,  Finland  passed  legislation  to  abolish  
smoking  with  the  Tobacco  Act  No.  693/1976  (as  
amended  through  2011)  by  preventing,  in  
particular,  children  and  adolescents  from  taking  
up  smoking  with  a  number  of  measures  restricting  
marketing  and  supply  of  tobacco  products  
including  a  ban  on  the  sale  of  snuff  (34).  Finnish  
civil  society  calls  for  2040  as  a  potential  endgame  
deadline  with  a  10%  annual  reduction  perspective  
(35)  while  a  recent  Government  declaration  aims  
for  2030  (36).  
  
Ireland  has  revisited  its  tobacco  control  strategy  in  
2013  and  has  proposed  60  recommendations  
towards  a  tobacco-­‐free  Ireland  projecting  that  less  
than  5%  of  the  population  will  smoke  by  2025  
(37).  
  
An  ongoing  discussion  on  the  endgame  for  
tobacco  control  is  moving  the  agenda  in  the  
United  Kingdom  (38).  Scotland  has  introduced  a  
new  tobacco  control  strategy  in  2013,  focusing  on  
creating  an  environment  where  young  people  
choose  not  to  smoke,  helping  people  to  quit  and  
protecting  people  from  second  hand  smoke,  
setting  out  the  actions  leading  to  creating  a  
tobacco-­‐free  generation  by  2034,  defined  as  a  
smoking  prevalence  among  the  adult  population  
of  5%  or  lower  (39).  
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Many  governments  elsewhere  have  pioneered  
new  initiatives.  Australia?s  recent  ground-­‐breaking  
move  to  introduce  plain  packaging  in  all  tobacco  
products15  eliminated  the  role  of  packaging  as  an  
advertisement  strategy  (41).  The  civil  society  in  
New  Zealand  has  launched  in  2009  a  target  and  a  
series  of  interventions  to  achieve  close  to  zero  
tobacco  smoking  prevalence  by  2020,  
???????????????????????????????????? ?????
Affairs  Parliamentary  Select  Committee  report  
recommendation  that  was  officially  supported  by  
the  Government  (42,  43).  The  Australian  state  of  
Tasmania  has  passed  in  its  Upper  House  the  
tobacco-­‐free  millennium  generations,  banning  
cigarette  use  to  anyone  born  after  2000  (44),  
following  Singapore?s  civil  society  proposal  (45).  
  
Tobacco  control  measures  considered  more  
radical  are  already  part  of  a  strategy  or  a  
regulation  in  some  countries  while  some  new  
ideas  aimed  to  move  from  ?tobacco  control?  to  
?the  end  of  the  tobacco  problem?  are  flourishing  
in  academic  papers.  Some  examples  of  existing  
and  proposed  tobacco  endgame  proposals  are  
listed  in  Table  12.  
  
                                                                                                                    
15The  law  went  into  effect  on  December  2012  in  
Australia  after  the  dismissal  of  a  tobacco  industry  
challenge  by  the  High  Court  of  Australia.  Ukraine  and  
some  Latin  American  countries  have  challenged  
Australia  over  the  issue  at  the  World  Trade  
???????????????????????????????????????????????????????
violations  of  intellectual  property  rights.(40).  
Nevertheless,  despite  being  an  evolving  topic,  the  
endgame  proposals  do  not  seem  to  be  developing  
for  most  WHO  regions,  including  the  European  
Region,  where  some  countries  are  taking  the  lead  
in  endgame  approaches  while  others  are  still  
struggling  to  implement  the  core  demand  
reduction  measures.  Furthermore,  it  was  recently  
acknowledged  that  countries  may  lack  the  
structure  needed  to  engage  in  an  endgame  
exercise  (55).  
  
Tobacco  is  a  drug  that  is  promoted  and  consumed  
within  the  framework  of  a  legal  product  that  is  
still  cultivated  apart  from  being  heavily  
manufactured  and  traded  in  the  Region.  It  could  
be  argued  that  the  future  of  tobacco  should  be  
framed  considering  tobacco  as  a  legal  product  and  
commodity  besides  its  well-­‐known  health-­‐related  
attribute  as  a  drug.  Addressing  these  three  
conditions  poses  a  major  challenge  in  the  mid-­‐  
and  long-­‐term  public  health  vision  of  the  Region.  
  
The  next  sections  of  the  report  explore  some  
ideas  of  future  scenarios  considering  the  three  
conditions:  tobacco  as  a  legal  product,  as  a  drug  
and  as  a  commodity.
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Examples  of  involved  actions   Implemented  initiatives  or  
academic  proposals  Ban  the  sales  and  import  of  tobacco  products   Eliminate  all  tobacco  sales  and  imports,  with  the  goal  of  reducing  consumption  to  near-­‐zero   Bhutan  ban  on  sales  and  imports  of  all  tobacco  products,  2004  (46)    New  Zealand?s  decision,  2011  
(47)  Smoke-­‐free  generation:  cohort  of  newborn   Re-­‐write  the  current  sales  restriction  on  under18s  to  include  a  generation  of  young  people  born  after  a  certain  date,  e.g.  1  January  2000  
Proposed  by  a  Singapore  advocacy  group  (TTFS  ?  Towards  Tobacco-­‐Free  Singapore),  2011  (45)  and  by  the  Australian  state  of  Tasmania  
(44)  License  to  smoke   Require  mandatory  smart  card  to  buy  tobacco  conditioned  to  acknowledgement  of  the  risk  and  agreement  to  limited  consumption  
Proposed  by  Chapman,  2012  
(48)  
Content  regulation   Reduce  dependence  induction  factors  and  product  appeal:  ban  additives  and  flavours,  reduce  nicotine  to  non-­‐dependence  levels  and  eliminate  ventilated  filters  
Ban  on  additives:  
 draft  EU  directive,  2013(12)  
 Canada,  2010(49)  
 Brazil,2012(50)    Proposed  by  Benowitz&Henningfield,  2013  
(51)  Reduce  availability:  a  
?sinking  lid?  on  tobacco  supply  
Reduce  progressively  the  number  and  types  of  establishments  that  sell  tobacco,  prohibit  new  licenses  and  transfers  of  licenses  
Proposed  by  Wilson  et  al.,  2013  
(52)  
Limiting  profits:  price-­‐cap  regulation   Introduce  a  system  of  price-­‐cap  regulation  to  address  the  market  failure  inherent  to  the  tobacco  industry  
Proposed  by  Branston&Gilmore  
(53)  
Source:  ASH  Action:  an  end-­‐date  for  tobacco  sales  (54).  
  
Future  scenario:  limiting  the  
legality  of  tobacco  
In  an  ideal  world,  tobacco  would  have  never  been  
legalized  (55).  Alternatively,  it  could  have  been  
converted  into  an  illegal  good  immediately  after  
the  first  reports  on  the  harmful  consequences  of  
smoking  were  released  in  the  early  1950s  in  
Europe  (56).  However,  although  the  tobacco  
industry  was  aware  of  the  damages  of  smoking  
(57),  it  took  decades  for  governments  to  consider  
a  regulatory  framework  to  tackle  the  tobacco  
epidemic,  first  as  the  pioneering  initiatives  in  
countries  such  as  Finland  and  Norway  and  later  by  
negotiating  an  international  treaty,  the  WHO  
FCTC.  
  
As  a  legal  product,  the  right  to  advertise,  promote  
and  manipulate  smoked  and  non-­‐smoked  tobacco  
has  historically  been  granted  to  the  tobacco  
industry  throughout  the  20th  century  and  is  still  
allowed  in  most  places,  including  in  European  
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countries,  where  the  TAPS  ban  is  less  regulated  
than  in  all  other  WHO  regions  (22).  In  the  future,  
on  a  supposed  strictly  regulated  tobacco  market,  
no  TAPS  will  be  used  or  even  remembered  by  the  
population,  thus  making  tobacco  products  
unappealing,  socially  unacceptable  and  more  
difficult  to  use.  
Legal  products  are  also  subject  to  taxes  and  price  
policies,  and  tobacco  is  no  different  from  any  
other  good,  becoming  a  desirable  source  of  
government  revenue.  Even  though  the  Region  is  
exemplary  in  increasing  taxes  and  prices,  this  
report  identifies  a  great  disparity  in  CRPs,  perhaps  
as  a  result  of  high-­‐  and  low-­‐tax  jurisdictions.  The  
resulting  price  differences  point  to  the  need  to  
harmonize  taxes  and  prices  in  the  Region  in  order  
to  prevent  consumers  from  purchasing  less  
expensive  products  from  low-­‐tax  jurisdictions,  
thereby  increasing  consumption  (58).    Ideally,  in  
the  future,  all  European  countries  would  have  
similar  high  prices  on  tobacco  products  as  one  
element  of  the  tobacco  endgame  in  the  Region.  
  
Legal  products  can,  in  principle,  be  used  in  social  
gatherings;  a  decade  ago,  this  was  the  case  for  
smoking  in  many  countries,  although  some  
already  considered  tobacco  smoke  a  nuisance.  
Some  studies  have  proven  that  second  hand  
smoke  harms  others  bringing  the  scientific  
evidence  needed  to  support  total  bans.  With  the  
introduction  of  smoke-­‐free  regulations,  the  
picture  has  changed  and  fines  for  violating  the  
smoking  ban  on  both  the  establishment  and  the  
smoker  transformed  smoking  into  an  anti-­‐social  
behaviour  for  many  societies.  Most  countries  in  
the  Region  provide  some  form  of  protection  from  
smoke  exposure  in  schools,  universities  and  
health  care  facilities,  but  the  majority  of  
countries  do  not  provide  smoke-­‐free  laws  in  all  
public  places.  Some  countries  in  Europe  still  have  
not  fully  implemented  this  simple,  easily  enforced,  
core  measure  of  the  WHO  FCTC,  a  situation  that  
hopefully  the  Region  will  not  need  to  confront  in  
the  future.  
  
Whether  a  product  such  as  tobacco  should  be  
legal  or  illegal  is  a  popular  discussion.  Comparing  
policies  to  counter  tobacco  use  with  those  to  
control  cannabis16  use  can  provide  governments  
with  interesting  insights  as  experiences  in  
                                                                                                                    
16  Cannabis  is  the  illegal  drug  most  used  in  the  EU.  
decriminalizing  and  discussions  to  legalise  
advance  in  Europe.  Apart  from  the  relevant  
perspective  of  consumers  as  polydrug  users  (e.g.  
cannabis  is  usually  smoked  with  tobacco  and  
associated  with  alcohol  drinking)  ?what-­‐if??
scenarios  on  how  market  controls  could  be  
transposed  from  tobacco  to  cannabis  in  a  post-­‐
legalization  environment  are  ignored  (59).  
  
The  fact  that  tobacco  is  by  far  the  most  important  
psychoactive  drug  used  in  Europe  and  that  users  
are  becoming  increasingly  marginalized  due  to  
stronger  tobacco  control  regulations  might  unite  
tobacco  products  with  a  restrictive  liberalization  
of  certain  drugs  such  as  marijuana  in  a  similar  
legal  framework.  The  fact  that  Bhutan  ?  the  only  
country  in  the  world  that  made  selling  tobacco  
illegal  ?  has  apparently  not  been  successful  in  
ending  tobacco  use17  points  towards  regulation  
rather  than  prohibition  (46).  This  scenario  would  
leave  the  Region  with  the  challenge  of  framing  
future  tobacco  control  policies  in  Europe  with  an  
eye  on  how  the  illicit  drugs  policies  are  
progressing  towards  legalization.  Eventually,  both  
could  be  subject  to  the  same  system,  sold  in  
designated  stores  and  dependent  on  a  
comprehensive  education  programme  associated  
with  a  strong  regulatory  approach  enforced  by  all  
countries  in  the  Region.  In  any  case,  despite  the  
fact  that  some  European  countries  are  recognized  
for  setting  a  global  example  for  tobacco  control,  
most  countries  still  need  to  fully  engage  in  the  
process  of  building  population  awareness  and  
change  social  norms  by  implementing  the  
WHOFCTC;  countries  more  advanced  in  the  treaty  
implementation  can  consider  testing  new  waters  
towards  a  tobacco  endgame.  
Future  scenario:  tobacco  as  a  drug  
Dependence  caused  by  any  tobacco  product  has  
been  diagnosed  as  a  mental  and  behavioural  
disorder  due  to  psychoactive  substance  use  (60).  
Many  or  most  of  tobacco  products?  contents  and  
emissions  were  barely  known  or  studied  in  the  
last  century  and  many  research  gaps  still  exist  to  
inform  policies.  The  addictive  nature  of  nicotine  
contained  in  tobacco  products  has  only  recently  
raised  sufficient  public  health  attention  to  engage  
                                                                                                                    
17  Bhutan  had  already  one  of  the  lowest  prevalence  of  
smokers  in  the  world  by  2004  (46).  
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the  health  sector  in  offering  information  and  
treatment  to  tobacco  users.  Seventy-­‐three  per  
cent  of  countries  in  the  Region  would  have  to  
consider  going  well  beyond  the  existing  
arrangements  by  increasing  the  availability  and  
display  of  quit  lines  information  on  all  packages.  
Mandatory  qualitative  information  on  
constituents  and  emissions  should,  in  the  future,  
equally  cover  the  present  information  gap  in  98%  
of  European  countries.  Interventions  to  reduce  
symptoms  of  nicotine  dependence  varies  across  
the  Region  (61)  and  different  views  exist  
regarding  research  and  policy  gaps  that  can  only  
be  addressed  after  identifying  how  many  tobacco  
users  need  treatment  and  drugs  to  quit(62).  In  
any  case,  the  use  of  combustible  tobacco  
products  is  becoming  socially  unacceptable  as  
smoking  areas  are  becoming  more  restricted,  
progressively  leaving  the  smoker  with  few  
remaining  options  than  to  quit.  
  
Harm  reduction  strategies  such  as  nicotine  
reduction  have  been  debated  for  years.  But  
tobacco  product  regulation  initiatives  have  not  
followed  suit  and  this  is  one  of  the  topics  that,  
due  to  the  evolving  scientific  evidence  associated  
with  limited  best  practices  at  country  level,  has  
not  yet  been  fully  established.18  
  
Flavours,  such  as  menthol,  vanilla  and  strawberry,  
are  increasingly  added  to  tobacco  products  to  
facilitate  experimentation  and  initiation  by  teens  
and  disadvantaged  groups  (64,  65).  A  ban  on  
additives  has  been  included  in  the  ongoing  
revision  of  the  EU  directive  proposal  banning  
flavours  and  increasing  health  warnings  in  tobacco  
packages.  Nevertheless,  the  tobacco  industry  is  
attempting  to  interfere  in  the  process  (66).  
  
Some  Nordic  countries  claim  success  in  policies  
that  switch  smokers  from  combustible  tobacco  
products  to  moist  snuff  as  a  harm  reduction  
strategy  (67)  while  other  European  countries  ban  
snus  (68).  New  alternative  products  such  as  ENDS  
attract  consumers  by  offering  what  is  claimed  to  
be  a  ?safer  cigarette?,  although  no  scientific  
evidence  of  their  safety  as  a  harm-­‐reduction  
product  or  their  efficacy  as  a  cessation  product  
                                                                                                                    
18The  WHO  FCTC  guidelines  for  Articles  9  and  10  are  in  
progress,  as  many  relevant  product  regulation  aspects  
need  further  development  (63).  
exists.  E-­‐cigarettes  fall  into  a  regulatory  gap  in  
most  countries,  escaping  regulation  as  drugs  and  
avoiding  the  controls  levied  on  tobacco  products.  
WHO  recommends  that  e-­‐cigarettes  should  be  
regulated  through  a  two-­‐pronged  approach  as  
both  tobacco  and  medicinal  products  to  prevent  
a  situation  in  which  loopholes  are  exploited  and  
e-­‐cigarettes  escape  control  (69).  
  
Oftentimes,  European  countries  either  regulate  e-­‐
cigarettes  as  medicines  or  tobacco  products,  if  at  
all  (70).  Among  other  concerns,  there  is  the  fear  
raised  by  the  scientific  community  on  the  impact  
of  e-­‐cigarettes  on  experimentation  and  initiation  
into  smoking  cigarettes,  particularly  by  young  
people  (71).  In  any  case,  it  seems  that  regulating  
any  product  that  contains  nicotine,  whether  it  is  
part  of  a  tobacco  product  or  not,  and  establishing  
progressive  reduction  of  nicotine  to  decrease  drug  
dependence  potential  seems  to  be  a  way  forward  
that  is  gaining  increasing  acceptance,  provided  it  
is  based  on  scientific  evidence.  
  
In  any  regulatory  framework,  information  about  a  
legal  drug  is  a  government  responsibility  and  a  
consumer  right.  Informing  about  the  potential  
dependence;  the  social,  economic,  
environmental  and  health  consequences;  access  
to  and  forms  of  treatment;  and  warning  against  
the  strategies  of  the  tobacco  industry  to  mislead  
the  public,  among  other  issues,  has  been  granted  
to  the  population  by  many  countries  in  the  
Region.  Nevertheless,  the  number  of  campaigns  
has  decreased  overtime,  at  times  because  the  
message  has  already  been  delivered.  Moreover,  
information  to  vulnerable  populations,  such  as  
young  people  and  the  poorly  educated  is  
contradictory  with  the  social  tolerance  to  
tobacco  use,  a  factor  that  has  high  importance  in  
shaping  behaviour.  Finally,  as  one  of  the  most  
simple,  non-­‐costly  and  far  reaching  health  
information  policies,  it  is  worrisome  that  many  
European  countries  still  have  no  pictorial  
warnings  or  even  warnings  on  all  tobacco  
products  including  smokeless  tobacco,  showing  
that  there  is  still  a  long  way  to  go  to  meet  the  
obligations  of  Article  11  of  the  WHO  FCTC  and  its  
respective  guidelines  before  considering  a  




In  this  future  scenario,  tobacco  products  persist  
in  the  legal  market  but  no  additives  will  be  
permitted.  Tobacco  products  will  be  less  
appealing,  socially  unacceptable  and  less  
palatable,  harsher  and  more  difficult  to  use.  Plain  
packaging  with  large  pictorial  warnings  and  
inserts  with  cessation  tips  will  be  the  norm.  
Furthermore,  the  decreasing  social  tolerance  to  
tobacco  smoke  ?  and  consequently  the  
marginalization  of  smoking  ?  will  naturally  
increase  the  demand  for  new  products.  They  can  
work  as  alternatives  to  tobacco  consumption  
provided  they  do  not  stimulate  experimentation  
and  initiation  of  tobacco  use.  In  the  case  that  
combustible  tobacco  products  are  progressively  
replaced  by  ENDS,  a  strict  regulated  market  with  
an  adequate  enforcement  structure  should  be  
considered.  This  includes  new  nicotine  delivery  
devices  that  will  enter  the  market,  an  intention  
already  announced  by  a  major  tobacco  company,  
raising  concerns  in  the  public  health  community  
(72).  
  
Future  scenario:  tobacco  as  a  
commodity  
In  the  framework  of  exchange  economics,  a  
commodity  is  a  good  that  can  be  traded  (73)  and  
in  the  case  of  tobacco,  a  commodity  that  has  a  
global  economic  significance.  It  is  therefore  
appropriate  to  consider  the  implication  the  
tobacco  trade  has  on  the  international  and  
national  political  scenario  and  potential  
implications  for  health  policies  by  understanding:  
 the  trends  of  national  and  international  
markets  and  how  they  affect  European  
countries;  
 the  tobacco  production  chain,  from  
growing  to  manufacturing  to  selling  and  
their  economic  and  social  implications;  
 the  illicit  trade  of  tobacco  products  and  its  
direct  and  indirect  consequences;  and  
 the  tobacco  industry:  private  and  state-­‐
owned,  transnational  and  national,  and  
direct  and  indirect  interference  with  
tobacco  control.  
  
Discussion  of  a  future  endgame  in  the  Region  
should  focus  on  tobacco  as  a  commodity.  
  
Europe´s  share  in  the  world  cultivation  of  tobacco  
is  small  and  accounts  for  about  4.7%  of  global  
production.  In  the  last  years,  the  EU  has  
implemented  a  successful  package  of  reforms  
eliminating  tobacco  subsidies  and  developing  
funding  programmes  to  support  farmers  in  
transition  to  alternative  production  activities.19  
Turkey  has  also  provided  subsidies  on  an  
elimination  programme  with  Government  support  
to  growers  willing  to  grow  other  crops.  As  a  result,  
tobacco  production  fell  by  48%  in  the  Region  and  
hectares  earmarked  for  tobacco  cultivation  
decreased  by  54%.  This  trend  is  driven  mainly  by  
decreases  in  production  in  some  European  
countries  in  both  the  western  and  eastern  parts  of  
the  Region.  The  EU  accounts  for  approximately  
82%  of  Europ???  total  production  ?  13  of  its  
members  are  tobacco  producers?  with  the  main  
producer  countries  Italy,  Bulgaria,  Poland,  Spain  
and  Greece  with  the  first  two  countries  
accounting  for  50%  of  tobacco  production  in  the  
Region.  Nevertheless,  some  countries  of  the  
former  Soviet  Union,  the  Russian  Federation  in  
particular,  have  increased  production  due  to  large  
investments  from  multinational  tobacco  
companies  in  the  local  cigarette  industry  (76).  The  
number  of  tobacco  farmers  in  the  Region  is  
around  86  000,  of  which  50%  come  from  Bulgaria,  
followed  by  Poland  and  Greece  (both  accounting  
for  17%)  (77).  In  Turkey,  207  000  families  were  
involved  in  tobacco  growing  in  2006  (78).  
  
Trade  of  tobacco  products  is  important  to  the  
Region.  In  2011,  Europe  imported  1  308  278  tons  
of  tobacco  and  the  main  importer  countries  were  
Belgium,  France,  Germany,  Greece,  the  
Netherlands,  Poland,  the  Russian  Federation  and  
the  United  Kingdom.  In  the  same  year,  the  Region  
exported  499  821  tons  of  tobacco  and  the  main  
exporter  countries  were  Belgium,  Turkey,  
Germany,  Greece  and  Spain  (76).  There  is  an  
intense  trade  flow  internally  among  the  EU  
member  countries  themselves.  
  
Effective  tobacco  control  policies  pose  a  threat  to  
the  tobacco  industry  and  their  business  (79).  
Therefore,  the  economic  success  of  the  tobacco  
industry  depends  not  only  on  appropriate  
strategies  to  put  the  products  on  the  market,  but  
                                                                                                                    
19 See Council Regulations (EC) No. 1782/2003 
(consolidated version) (74) and No. 864/2004 (75). 
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also  on  the  macroeconomic  environment  and  the  
political  and  regulatory  frameworks  (80).  
Additionally,  the  globalization  of  goods  has  
brought  new  challenges  to  the  Region  with  the  
introduction  of  new  tobacco  products  such  as  
kreteks  and  waterpipes  into  the  market  (81)  and  
illicit  trade  showing  alarming  statistics.  EU  losses  
associated  with  tax  evasion  from  smuggling  and  
counterfeit  products  are  estimated  to  be  10  
billion  euros  per  year  (82).  In  order  to  join  efforts  
against  the  illicit  tobacco  market,  the  European  
Commission  has  made  a  multiyear  agreement  in  
2010,  which  consisted  of  a  legally  binding  
arrangement  signed  by  the  European  Commission,  
the  European  Anti-­‐Fraud  Office  and  British  
American  Tobacco.  The  main  pathways  for  
smuggled  cigarettes  in  Europe  are  located  in  
eastern  Europe  and  the  former  Soviet  Union  (83).  
  
The  numbers  above  give  an  idea  of  the  
complexities  involved  in  the  agriculture,  
production,  trade  and  distribution  of  tobacco  
products  in  a  region  that  has  fundamental  
differences  in  programmes  and  policies  for  and  
against  tobacco  use  and  where  trade  arguments  
are  part  of  the  discussion.  Four  major  
multinational  tobacco  companies  operating  in  the  
Region  (Phillip  Morris  International;  British  
American  Tobacco,  including  later  acquisitions  of  
Turkish  TEKEL  and  Scandinavian  Skandinavisk  
Tobakskompagni;  Japan  Tobacco  International;  
and  Imperial  Tobacco  Group)  have  market  shares  
and  develop  well-­‐known  strategies  to  oppose  
advances  in  tobacco  control. 
  
In  this  scenario,  any  endgame  proposal  will  be  
unrealistic  if  tobacco  is  not  considered  as  a  
commodity.  If  sectors  as  diverse  as  agriculture,  
trade,  antifraud  and  finances  are  not  serious  
about  shifting  the  focus  from  trade  to  health,  not  
prioritizing  trade  over  health.  Governments  
wishing  to  give  priority  to  public  health  and  to  
resist  the  financial  pressure  of  the  tobacco  
industry  should  consider  certain  steps:    
 eliminate  financial  incentives  to  the  
establishment  of  the  tobacco  industry  in  
new  markets;  
 limit  trade  by  taxing  heavily  all  cross-­‐
border  moves  of  tobacco  products;  
 reduce  profits  of  the  tobacco  industry  by  
systems  such  as  price-­‐cap  regulations  or  
any  other  process;  
 divest  shares  in  pension  funds  and  other  
investments  sources;  and    
 combat  illicit  trade.  
  
Reducing  the  financial  power  of  the  tobacco  
industry  is  an  important  move  to  allow  public  
health  to  take  priority.  Creating  mechanisms  to  
ensure  transparency  in  government  ??????????  
interactions  with  the  tobacco  industry  to  resist  
their  lobbies  is  part  of  this  equation.  
  
The  WHO  FCTC  and  the  Protocol  to  Eliminate  Illicit  
Trade20  are  key  in  providing  the  basic  framework  
on  how  Parties  can  address  some  of  these  
elements  (84)  and  should  be  considered  as  a  
priority  now  and  in  the  future.  
  
Furthermore,  the  specific  endgame  policies  
addressing  tobacco  as  a  commodity  should  be  
sufficiently  robust  to  withstand  challenges  under  
the  World  Trade  Organization  and  other  trade  
agreements  within  Europe  (Porter  G,  van  der  Eijk  
Y.  Would  a  tobacco  phase-­‐out  violate  world  trade  
law?,  unpublished  observations).  
  
A  roadmap  for  a  tobacco-­free  
Europe  
The  future  of  tobacco  products  can  be  addressed  
taking  into  consideration  three  major  
characteristics:    
  
1. the  drug  that  causes  dependence    
2. the  product  that  enjoys  a  legal  status  
3. the  commodity  that  is  traded.  
  
In  preparing  to  engage  in  a  tobacco  endgame,  
these  characteristics  should  be  considered  in  the  
mid-­‐and-­‐long  term  with  an  ultimate  focus  in  
public  health.  
  
                                                                                                                    
20Ten  out  of  37  signatories  of  the  Protocol  to  Eliminate  
Illicit  Trade  are  Parties  from  the  European  Region  by  




In  the  Region,  Finland,  Ireland  and  the  United  
Kingdom  (Scotland)  are  paving  the  way  for  other  
countries  to  move  to  the  projected  reduction  of  
less  than  5%  of  smokers  or  tobacco  users  in  their  
population.  In  order  to  reach  the  ?readiness?  to  
engage  in  the  endgame,  evidence-­‐based  policies  
should  be  implemented  while  some  innovative  
approaches  should  be  tested  according  to  the  
tobacco  control  status  and  the  level  of  the  
tobacco  epidemic  in  the  country.  This  could  
include  some  possible  next  steps:  
  
1. In  line  with  global  best  practices  and  
success  stories,  implement  fully  the  WHO  
FCTC  and  its  guidelines  as  the  first  major  
step  forward  for  most  countries  in  the  
Region;  this  is  a  requirement  especially  
because  the  treaty  measures  provide  the  
minimum  that  should  be  done  and  to  
confront  the  epidemic.  
2. Become  a  Party  to  the  Protocol  to  
Eliminate  Illicit  Trade  of  Tobacco  
Products  and  implement  fully  the  
Protocol  after  entry  into  force.  
3. Prevent  the  undue  interference  of  the  
tobacco  industry  and  their  interest  
groups  in  public  health  and  tobacco  
control  policies,  by  ensuring  transparency  
in  the  eventual  interactions  between  
government  representatives  and  the  
tobacco  industry  and  a  full  
implementation  of  WHO  FCTC  Article  5.3  
and  guidelines.  
4. Move  towards  de-­‐normalizing  the  
tobacco  industry  by  reducing  their  
economic  power  and  influence  is  
essential  to  restrict  the  importance  of  the  
global  tobacco  market  and  consequent  
threats  to  public  health  in  the  name  of  
trade  arguments.  
5. Consider  establishing  an  increasingly  
stricter  regulatory  framework  for  tobacco  
products  in  line  with  the  needed  
enforcement  structure  to  restrict  to  a  
maximum  limit  tobacco  affordability  and  
availability  while  ensuring  
comprehensive  support  to  tobacco  users  
in  their  demand  for  quitting.  
6. Consider  harm  reduction  strategies  as  
part  of  the  endgame  scenario  outlining  
carefully  a  strict  regulatory  framework.  
Nevertheless,  ensure  that  these  
strategies,  including  novel  products,  are  
cost-­‐effective  and  that  no  adverse  
effects,  such  as  increasing  
experimentation  and  initiation  are  
identified.  
  
All  in  all,  the  immediate  and  full  
implementation  of  the  WHO  FCTC  will  
already  provide  a  better  and  healthier  
world  to  the  ???????????????  generations.  
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Annex  1.  Regional  summary  of  measures  within  WHO  FCTC  
Table  1.Summary  of  MPOWER  measures  in  the  Region  
  
  
Europe 2012 Indicator and compliance Change since 2010
COUNTRY M P O E R P O W E R 
M ON IT OR IN G SM OKE-F R EE 
P OLIC IES
C ESSA T ION  
P R OGR A M M
ES
H EA LT H  
WA R N IN GS
M A SS M ED IA A D VER T ISIN
G B A N S

















Albania 24% III IIIIIIII 61% ?
. . . Data not reported/not available
Andorra . . . . . . ? 46% ? ?
??????????????????????????????????
Armenia 19% III IIII 25% ?
Austria 44% IIIII IIIIII 74%
Azerbaijan . . . IIIIIII IIIIII 19%
Belarus 24% ? III 42%
Belgium 21% IIIIIIII IIIIIIIIII 76%
Bosnia and Herzegovina 32% ? IIIII 75% ?
Bulgaria 33% ? IIIII 84% ?
Croatia 29% IIIIIII IIIIII 71%
Cyprus 27% IIIIIIII IIIIIIIIII 76% ?
Czech Republic 24% IIIIIIII IIIIIIIII 78%
Denmark 20% ? . . . 79% ? ? ?
Estonia 25% IIIIIII IIIIIIIII 77% ?
Finland 17% IIIIIIIIII IIIIIIIII 80%
France 31% . . . . . . 80%
Georgia 23% IIIIIII 58%
Germany 24% IIIIIII IIIIIIIII 73%
Greece 36% . . . . . . 82% ?
Hungary 29% IIIIIIIIII IIIIIIIIII 84% ? ?
Iceland 14% IIIIIIIIII IIIIIIIIII 57% ?
Ireland . . . . . . . . . 79% ?
Israel 22% . . . . . . 84%
Italy 21% ? IIIIIIIIII 75%
Kazakhstan 20% . . . . . . 30%
Kyrgyzstan 20% . . . . . . 66% ?
Latvia 26% . . . . . . 79%
Lithuania 27% IIIIIIII IIIIIIIII 75%
Luxembourg 19% . . . . . . 71%
Malta 22% IIIIIIII IIIIIIII 77%
Monaco . . . . . . ? . . .
Montenegro . . . IIIII IIIIIIIIII 81% ? ?
Netherlands 20% ? IIIII 72%
Norway 19% IIIIIIIIII IIIIIIIIII 73%
Poland 26% IIIIIII IIIII 80%
Portugal 19% IIIIIIII IIIIII 76%
Republic of Moldova 20% II IIII 44%
Romania 25% IIIIIII IIIIIIIII 73% ?
Russian Federation 34% ? . . . 40%
San Marino . . . . . . . . . 74%
Serbia 29% IIIII IIIIIII 76% ?
Slovakia 23% IIIIIII IIIIIIIII 84%
Slovenia 21% IIIIIIII IIIIIII 80%
Spain 26% IIIIIIIIII IIIIIIIIII 79%
Sweden 11% ? IIIII 74%
Switzerland 19% ? IIIIIIII 62%
Tajikistan . . . ? . . . 31%
The former Yugoslav Republic of Macedonia . . . . . . . . . 71%
Turkey 24% IIIIIIIIII IIIIIIIIII 80% ? ?
Turkmenistan . . . . . . ? 30% ?
Ukraine 25% . . . . . . 67% ?
14% IIIIIIIIII IIIIIIIII 80%
Uzbekistan 10% . . . . . . 29% ?
Change in POWER indicator group, up or down, since 2010
United Kingdom of Great Britain 
and Northern Ireland
W
A D ULT  D A ILY 
SM OKIN G 





? Estimates not available
30% or more 
From 20% to 29.9% 
From 15% to 19.9% 
Less than 15% 
No known data or no recent data or data that are not both recent and representative
Recent and representative data for either adults or youth
Recent and representative data for both adults and youth
Recent, representative and periodic data for both adults and youth
Data not reported/not categorized
Up to two public places completely smoke-free
Three to five public places completely smoke-free
Six to seven public places completely smoke-free




NRT and/or some cessation services (neither cost-covered)
NRT and/or some cessation services (at least one of which is cost-covered)
National quit line, and both NRT and some cessation services cost-covered
Data not reported
No warnings or small warnings
Medium size warnings missing some appropriate characteristics OR large warnings missing many appropriate 
characteristics
Medium size warnings with all appropriate characteristics OR large warnings missing some appropriate characteristics
Large warnings with all appropriate characteristics
Data not reported
No national campaign conducted between January 2011 and June 2012 with duration of at least three weeks
National campaign conducted with 1 - 4 appropriate characteristics
National campaign conducted with 5 - 6 appropriate characteristics
National campaign conducted with at least seven appropriate characteristics including airing on television and/or radio
Data not reported
Complete absence of ban, or ban that does not cover national television, radio and print media
Ban on national television, radio and print media only
Ban on national television, radio and print media as well as on some but not all other forms of direct and/or indirect 
advertising
Ban on all forms of direct and indirect advertising
Data not reported
<= 25% of retail price is tax 
??????????????????????????????
??????????????????????????????











Separate, completely enclosed smoking rooms are allowed if they are separately ventilated to the outside and/or kept under 
negative air pressure in relation to the surrounding areas. Given the difficulty of meeting the very strict requirements 
delineated for such rooms, they appear to be a practical impossibility but no reliable empirical evidence is presently 
available to ascertain whether they have been constructed.
Policy adopted but not implemented by 31 December 2012
Data not substantiated by a copy of the legislation
Change in POWER indicator group, up or down, between 2010 and 2012.  Some 2010 data were revised in 2012. 
2012 grouping rules were applied to both years.
PLEASE REFER TO TECHNICAL NOTE I FOR DEFINITIONS OF CATEGORIES
SYMBOLS LEGEND
HEALTH W ARNINGS: HEALTH W ARNINGS ON CIGARETTE PACKAGES
MASS MEDIA: ANTI-TOBACCO CAMPAIGNS
ADVERTISING BANS: BANS ON ADVERTISING, PROMOTION AND SPONSORSHIP
TAXATION: SHARE OF TOTAL TAXES IN THE RETAIL PRICE OF THE MOST W IDELY SOLD BRAND OF CIGARETTES
COMPLIANCE: COMPLIANCE W ITH BANS ON ADVERTISING, PROMOTION AND SPONSORSHIP, AND ADHERENCE 
TO SMOKE-FREE POLICY
Complete compliance (8/10 to 10/10)
Moderate compliance (3/10 to 7/10)
Minimal compliance (0/10 to 2/10)
ADULT DAILY SMOKING PREVALENCE* : AGE-STANDARDIZED PREVALENCE RATES FOR ADULT DAILY SMOKERS OF 
TOBACCO (BOTH SEXES COMBINED), 2011
* The figures  should  be used  s trict ly fo r the purpose o f d rawing  comparisons  across  countries  and  must  no t  be used  to  es t imate abso lute number o f daily tobacco  smokers  in a 
country.
MONITORING: PREVALENCE DATA
SMOKE-FREE POLICIES: POLICIES ON SMOKE-FREE ENVIRONMENTS
CESSATION PROGRAMMES: TREATMENT OF TOBACCO DEPENDENCE
Source:  WHO  report  on  the  global  tobacco  
epidemic,  2013:  enforcing  bans  on  tobacco  
advertising,  promotion  and  sponsorship.  
Geneva:  World  Health  Organization;  2013  
(http://www.who.int/tobacco/global_repor
t/2013/en/index.html,  accessed  16  October  
2013).  
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